







NEW TECHNOLOGIES FOR LIVE CELL FLUORESCENCE 















A dissertation submitted to Johns Hopkins University in conformity with the requirements 




















 Post translational modifications (PTMs) of proteins serve critical roles in both 
signal transduction as well as gene regulation. Phosphorylation is an important means by 
which signals are transmitted, processed, and amplified within a cell, while methylation 
is a critical regulator of chromatin organization mediated by histone proteins. The  spatial 
distribution and temporal dynamics of these PTMs must be tightly controlled to allow for 
proper functioning. In signaling pathways, distinct spatiotemporal patterning of signaling 
activities is a critical means by which cells use the same molecular components to 
regulate diverse functionalities. In gene regulation, precise spatial organization of histone 
methylation allows for the proper distributions of heterochromatin and euchromatin, 
controlling which parts of the genome are transcriptionally active or repressed.  
 In this dissertation, we discuss three new genetically encodable fluorescence 
technologies to expand the information we can obtain about the spatiotemporal dynamics 
of PTMs in real time in live cells. First, we discuss a new suite of genetically encodable 
fluorescent biosensors that are both single-color and ratiometric. These FLuorescent 
Anisotropy Reporters (FLARE) are based on homo-FRET, and they allow for 
multiparameter imaging of cell signaling activities, such as kinase activity and second-
messengers. We then present a panel of biosensors called Fluorescent fLuctuation 
INcrease by Contact (FLINC) sensors that allow for the creation of sub-diffraction limit 
resolution maps of kinase activity. They were then used to map highly localized signaling 
microdomains of the Protein Kinase A (PKA) pathway in the plasma membrane. Finally, 
we describe a new fluorescent probe for superresolution mapping of tri-methylated 
histone 3 lysine 9 (H3K9me3), a critical histone modification for regulating the formation 
 iii 
of heterochromatin in the nucleus. By engineering a mutant of the chromobox homolog 
protein 1 (CBX1) with high affinity for H3K9me3 and fusing it with a photoactivatable 
fluorescent protein, we demonstrate the ability to create sub-diffraction limit resolution 
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Chapter 1 Post-Translational Modifications in Signal 








A wide array of chemical modifications to proteins dramatically alter their 
function. These post-translational modifications (PTMs) are critical for many cellular 
functions, such as processing information, maintaining the proper levels of protein, 
regulating the cell cycle, and controlling gene expression. The chemical modification 
may direct the protein to the proper localization, act as a switch to regulate the activity of 
the enzyme, affect interactions with other cellular structures, control the degradation of 
the protein, or a wide variety of other functions.  
The controlled addition or removal of PTMs allows the cellular machinery of a 
cell to respond rapidly to changing conditions, both internally and externally. An enzyme 
can act as a sensor to detect a signal, which it relays by modifying effectors with PTMs. 
These effectors in turn either further transmit the signal to other effectors or mediate 
other cellular processes. The enzymes that conditionally facilitate the addition or removal 
of PTMs control the spatial patterning within the cell and temporal dynamics of the 
modification. By tightly regulating PTMs in space and in time, these enzymes help 
ensure, for example, that the proteins they modify are activated, expressed, degraded, 
and/or localized at the right place and time in an often rapidly changing cellular 
environment. 
 This tight spatiotemporal regulation of PTMs motivates the development of novel 
tools for monitoring post-translational modifications. Presented here are three novel 
technologies that that push the limits of our abilities to study the spatiotemporal features 
of phosphorylation and methylation, two critical PTMs for signal processing and gene 
expression regulation, respectively. Phosphorylation cascades form the backbone of 
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signal transduction pathways, allowing the cell to sense extra-cellular signals, transmit 
and process that information, and elicit the appropriate cellular response. Methylation, on 
the other hand is a critical regulator of histone proteins, which package DNA and regulate 
gene expression. In this dissertation, we present a suite of genetically-encodable 
molecular tools compatible with live-cell fluorescence imaging that expand the amount of 
information we can gather about these critical PTMs in terms of their spatial distribution 
within the cell and their temporal dynamics.  
 
Spatiotemporal Regulation of Kinase Activity in Signal Transduction 
Cells detect, process, and respond to changes in its external and internal 
environment through networks of interconnected and coordinated signaling pathways. 
Receptors sense signals, including chemical, optical, or mechanical inputs, and then 
transmit these signals to a wide variety of effectors, which further process, amplify, relay, 
and interpret the signals. These pathways allow the cell to elicit the appropriate cellular 
responses to a changing environment or cellular state. Signaling activities in a cell 
include addition or removal of PTMs (principally phosphorylation), induction of protein-
protein interactions, and the recruitment of second-messengers. Protein kinases, which 
add phosphate groups to other proteins, form the backbone of these signaling 
transduction pathways. There are approximately 500 protein kinases and approximately 
100,000 phosphorylation sites in the human genome1,2. 
The correspondence between cellular input and output in signal transduction 
pathways are far from one-to-one. The same signal may trigger many different cascades, 
pathways often cross-talk with one another, and one effector may control many cellular 
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processes. The number of genes involved in signal transduction, moreover, is surprisingly 
low compared to the number of cellular processes that they regulate, which implies that 
signaling pathways must share components3. Noise further limits the amount of 
information processed by individual signaling pathways4. These observations suggest that 
cell fate decisions are not encoded simply at the gene or protein level. 
For a kinase signaling cascade to allow cells to make many cellular decisions, 
such as whether to migrate, proliferate, undergo cytoskeletal rearrangement, or initiate 
apoptosis, key components of the pathway are regulated both in terms of their temporal 
dynamics and spatial distribution across the cell. Different spatiotemporal profiles in 
activation of protein kinases result in different gene activation profiles and thus activate 
different cellular processes. Spatial regulation of kinase activity may occur, for example, 
through targeting of the enzyme to particular subcellular compartments, the localized 
degradation of signaling molecules, complex patterning on a membrane, and/or by 
coordination with anchoring proteins. Temporal dynamics of kinase activity, on the other 
hand can be mediated by the presence of phosphatases, for example, or can be the result 
of particular signaling motifs in the pathway architecture, such as feedback loops. 
Signaling activities may be highly transient, sustained over longer periods of time, or 
exhibit more complex temporal patterns, such as oscillations. 
 
Spatiotemporal regulation of cAMP/PKA signaling Pathway  
 The cyclic adenosine monophosphate (cAMP)/cAMP-dependent protein kinase 
(PKA) pathway, a highly versatile and intensively studied signaling pathway expressed in 
nearly all mammalian tissues, undergoes many levels of compartmentalization and 
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temporal control5,6. The pathway is initiated by a ligand, such as a hormone or 
neurotransmitter, binding to a G-coupled protein receptor (GPCR), which in turn 
activates a heterotrimeric G protein, composed of a stimulatory Gα (Gsα) subunit and a 
Gβγ subunit. Gsα is activated when the GPCR acts as a guanine nucleotide exchange 
factor (GEF), causing the Gsα to unbind guanine diphosphate (GDP) and bind guanine 
triphosphate (GTP). This change causes Gsα to unbind from the Gβγ heterodimer and 
associate with the transmembrane adenylyl cyclase (tmAC), which begins to convert 
molecules of free ATP into cAMP. cAMP acts a second messenger, which activates a 
number of effectors, including the cAMP-dependent protein kinase (PKA), a 
heterotetrameric holoenzyme composed of two catalytic domains (C) and two regulatory 
(R) domains. cAMP binding to the C domain causes the R domains to move out of the 
way of the active site, resulting in the phosphorylation of downstream effectors, including 
transcription factors, metabolic enzymes, and ion channels regulators. The precise 
functional output of this pathway in a particular context is controlled largely by the 
spatial and temporal organization of the pathway. This regulation is caused by spatial 
restriction of cAMP into different pools as well as the binding of PKAs and other critical 
components of the pathway to anchoring proteins called A-kinase anchoring proteins 
(AKAPs).  
 One of the principal ways that the cAMP/PKA pathway is spatiotemporally 
regulated is through localized pools of cAMP, and subsequently localized PKA activity7. 
These localized signals are mediated by organization of components of the pathway 
among membrane subdomains, the localized degradation of cAMP, as well as anchoring 
of pathway components onto anchoring proteins. The spatial distribution of GPCRs, G-
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proteins and tmACs between different subdomains of the plasma membrane, such as lipid 
rafts and non-rafts regions, contributes to the spatiotemporal features of the cAMP 
responses. Disruption of lipid rafts, for instance, increases the amplitude and duration of 
cAMP responses upon signaling through β2-adrenergic receptor  (β2AR), which 
associates with membrane rafts, but not for prostaglandin E (PGE) receptor, which is 
excluded from membrane rafts8. Likewise, in β2AR-mediated signaling the disruption of 
raft domains is associated with enhanced PKA activation, while the presence of rafts is 
associated with basal PKA activity in the vicinity of the rafts9. Different isoforms of 
tmACs also have different distributions among membrane subdomains, which establish 
different spatiotemporal features of cAMP10–13.  
In addition to segregation of components of the cAMP/PKA pathway into 
different membrane subdomains, spatial regulation of cAMP is also mediated by 
localized activity of phosphodiesterases (PDEs), which hydrolyze cAMP. In particular 
PDEs are involved in establishing cAMP gradients between cellular compartments, either 
acting as a diffusion barrier or as a cAMP sink7. One example of this type of regulation is 
found in cardiac myocytes, where stimulation of the β1-adrenergic receptor (β1AR) 
results in PKA phosphorylating phospholamban (PLB) at the sarcoplasmic reticulum 
(SR) and subsequently increased calcium reuptake to the SR14. However, stimulation of 
PGE2 does not result in PKA activity at the SR. It has been shown that PGE2 stimulation 
leads to activation of PDE4D, which blocks diffusion of cAMP from the membrane to the 
SR and thus prevents activation of PKA in the vicinity of the SR. Furthermore, inhibition 
of PDE4 can partially remove this cAMP gradient, allowing for PKA activity at the SR 
upon PGE2 stimulation.  
 7 
 A-kinase anchoring proteins (AKAPs) are also key regulators of the spatial and 
temporal features of the PKA pathway. AKAPs, targeted to particular subcellular 
locations, coordinate the positions of GPCRs, G-proteins, the PKA holoenzyme, PDEs, 
phosphatases, and PKA effectors to create highly localized and functionally distinct 
signaling complexes, called signalosomes. These complexes amplify and accelerate 
particular signaling events within the signalosome while preventing other effects outside 
of the signalosome. For example, AKAP79 binds PKA, βARs, several isoforms of tmAC, 
calcium dependent protein kinase (PKC), calcineurin, the voltage-gated L-type calcium 
channels, and M-type potassium channels15–17. Poly-basic regions on the AKAP79, 
further, localizes the AKAP to the plasma membrane through binding to phospholipids18, 
and palmitoylation also targets it to lipid rafts19. This signalosome serves as a point of 
convergence between cAMP-mediated and calcium-mediated signaling, allowing for a 
coordinated regulation of the ion channels with which it associates.  
 
Spatiotemporal regulation of the MAPK/Erk cascade  
 Like the cAMP/PKA pathway, the mitogen activated protein kinase (MAPK)/Erk 
cascade undergoes tight spatiotemporal regulation that determines the ultimate cellular 
response. The MAPK/Erk pathway is initiated by the binding of a ligand to a receptor 
tyrosin kinase (RTK), which upon ligand binding undergoes dimerization and 
autophosphorylation on tyrosine residues. Binding of growth factor receptor bound 
protein 2 (Grb2) to the phosphotyrosine on the RTK then recruits and activates a GEF, 
called son of sevenless (SOS), which mediates the exchange of a GDP for a GTP on the 
small GTPase Ras and activates it. Ras then recruits the serine-threonine kinase Raf to 
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the membrane, priming it for activation. Raf then phosphorylates Mek, a protein kinase 
with dual serine/threonine and tyrosine specificities. Mek then phosphorylates dual 
threonine-tyrosine sites on Erk, a MAPK that then phosphorylates a large number of 
downstream effectors, such as the kinase Rsk as well as a number of transcription factors 
in the nucleus. 
The kinetics of Erk activation and inactivation has been shown to determine the 
phenotypic response. For example in the pheochromocytoma cell line PC-12, transient 
activation of Erk activity from epidermal growth factor (EGF) stimulation results in cell 
proliferation20–23. On the other hand, sustained Erk activity from nerve growth factor 
receptor (NGF) causes leads to neurite outgrowth, a sign of cellular differentiation. Many 
mechanisms may account for the difference in Erk activity dynamics when the pathway is 
activated by the two different ligands. These include differential kinetics in receptor 
degradation or recycling upon stimulation with EGF or NGF. Furthermore, it has been 
suggested that a positive feedback loop between Erk and Raf functions in the case of 
NGF signaling to sustain Erk activity, while a negative feedback loop in the case of EGF 
signaling may account for the transience23. Cross-talk between the PKC and PKA 
pathways has also been implicated in determining the cellular response to activation of 
the MAPK/Erk pathway. Raf Kinase Inhibitor Protein (RKIP), for example, blocks the 
interaction between Raf and Mek and serves as a negative regulator of the MAPK/Erk 
pathway24. Phosphorylation of RKIP by PKC in the case of NGF, but not EGF signaling, 
releases RKIP from Raf, allowing activation of Mek and possibly a direct positive 
feedback loop between Erk and Raf25. Likewise, crosstalk with the PKA pathway for 
both NGF and EGF signaling has also been shown, potentially implicating cAMP/PKA 
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signaling as another control on Erk activity dynamics. Both NGF and EGF lead to PKA 
activity in the vicinity of the plasma membrane, but not in the cytosol, with this gradient 
of activity mediated by PDE326. Furthermore, this PKA activity is transient in the case of 
EGF stimulation but sustained in the case of NGF stimulation.  
 In addition to temporal regulation of Erk activity resulting in functional 
specificity of the pathway, spatial organization of Erk activity is also critical for 
determining the functional output. Compartmentalization as well as scaffolding both 
plays important roles in determining the phenotypic output of MAPK/Erk pathway 
stimulation. With regards to compartmentalization, translocation of Erk to the nucleus 
and subsequent activation of its transcription factor effectors has been shown to be 
essential for proliferation in PC-12 cells and other cell types22,27. However, retention of 
Erk in the cytosol inhibits survival and proliferation signals as well as activating some 
pro-apoptotic proteins28. Furthermore, like in the case of AKAPs in cAMP/PKA 
signaling, scaffolds also integrate, coordinate, and direct the signaling of the MAPK/Erk 
pathway at key locations within the cell3,29. Scaffolds for components of the MAPK/Erk 
pathway fine tune the dynamics of the cascade, localize the signal to particular sub-
cellular regions, and act as allosteric regulators. For example, the scaffold Kinase 
Suppresor of Ras (KSR) binds to MEK in the cytosol in quiescent cells. However, upon 
activation of Ras, it translocates to the nucleus and binds Raf and Erk. By bringing 
together the key components of the kinase cascade into a single multi-protein complex, 
KSR fine-tunes the dynamics of signaling30. KSR also acts as an allosteric regulator of B-
RAF and aids in its dimerization and subsequent activation31.  
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The cAMP/PKA and the MAPK/Erk pathways share similar strategies for 
achieving spatiotemporal regulation, including compartmentalization, scaffolding, cross-
talk, organization among plasmallemal subdomains, and feedback. These strategies allow 
the same protein components control a large number of cellular processes in a specific 
and context-dependent way.  
 
Methods for Studying Spatiotemporal Regulation of Signaling Pathways  
 Traditionally, the dynamics of kinase activities were studied through in vitro 
biochemical assays, such as Western blotting, and immunofluorescence. Because 
Western blotting requires lysing a large population of cells, it provides bulk information 
about the levels of a particular protein or PTM within a population at a particular moment 
in time. It also does not provide single cell information or information on the variability 
among different cells. Dynamic experiments require the multiple repeats in different 
populations of cells and preparing separate blots at each time point. Moreover, 
information on the sub-cellular compartmentalization of signaling can be obtained 
through cellular fractionation. However, through in vitro assays, it is difficult to study 
more complex spatial arrangements of signaling activities. Immunofluorescence, on the 
other hand, does allow for single-cell observations and detailed spatial information, but it 
is performed in fixed cells, which prevents observations of dynamic processes in real 
time. 
 To overcome these challenges, the development of genetically-encodable 
fluorescent biosensors based on fluorescent proteins (FPs) has allowed the monitoring of 
a variety of signaling activities in live cells in real time. Genetic encodability of these 
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molecular tools allows the researcher to take advantage of the cellular machinery to 
synthesize the biosensor. Furthermore, it allows targeting to particular subcellular 
locations using known targeting sequences, making them well-suited for spatiotemporal 
studies. 
These biosensors work by coupling a molecular switch regulated by a particular 
signaling activity with a change in fluorescence of an FP32. The molecular switch could 
be the enzyme of interest if a substantial change in conformation occurs, such as in the 
case of the myosin light chain kinase (MLCK) sensor33,34. More commonly for kinase 
activity sensors, however, the switch is composed of two proteins or protein domains that 
bind or unbind in the presence of an activity. The switch for many kinase activity 
reporters (KARs), such as the PKA activity reporter (AKAR)9,35, Erk kinase activity 
reporter (EKAR)36, and PKC activity reporter (CKAR)37, are composed of a substrate 
peptide of the kinase of interest as well as a phosphoaminoacid binding domain, that 
binds the substrate after phosphorylation by the kinase of interest. 
This switch must be coupled with a change in fluorescence, which may be a 
change in the emission ratio between two FPs in a ratiometric reporter or a change in the 
intensity of a single wavelength in an intensiometric reporter. Most kinase activity 
reporters are ratiometric biosensors based on Forster’s Resonance Energy transfer, a non-
radiative, distance-dependent energy transfer from a donor fluorophore to an acceptor 
fluorophore. This transfer requires that the emission spectrum of the donor overlaps with 
the excitation spectrum of the acceptor. It further requires that the donor and acceptor 
fluorophores to be in proximity, within a distance of approximately 10 nm or less.  
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Single-color reporters, on the other hand, can rely on several designs for 
modulating the fluorescence output. Some sensors use an FP with an impaired β-barrel, 
which is designed to switch conformations and thus change fluorescence upon 
modulation of the molecular switch32. While this design is more common among small 
molecule sensors, such as the calcium GCaMP family of sensors38,39, a similar design in 
the sinphos sensors for monitoring insulin receptor kinase induced tyrosine 
phosphorylation40. Fragment complementation is another single-color method for 
connecting a protein-protein interaction with a change in fluorescence or 
bioluminescence41. In this technique, an FP or bioluminescent protein is divided into two 
non-functional fragments, which are fused to two proteins of interest. Upon binding of 
the two proteins, the fragments reconstitute into a working FP or bioluminescent protein. 
The reconstitution of FPs is irreversible, while the reconstitution of bioluminescent 
proteins is reversible32. Therefore, for reversible processes like kinase activity, 
luminescence is favorable for this design; a luminescent version of AKAR and CKAR 
based on fragment complementation, called LumAKAR,and LumCKAR, has been 
developed42.  
 A relatively new approach, using dimerization dependent FP, can in principle be 
used to create sensors that are either single-color or ratiometric43–45. ddFPs require two 
FPs, one called A whose fluorophore is quenched in the monomeric state, and the other 
called B that is completely non-fluorescent. The heterodimerization of A and B, which 
can be modulated by a molecular switch of interest results in an increase in the 
fluorescence of A. A ratiometric variant of this design, called Fluorescent Protein 
Exchange45, uses a green and red variants of A (GA and RA, respectively), that share a 
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binding partner B. B is exchanged from GA to RA in the presence of an activity of 
interest, resulting in a change in the ratio of green to red fluorescence. A FPX based Erk 
sensors based on EKAR has been demonstrated. 
 While all of these biosensors have the advantage of genetic encodability and the 
ability to monitor processes at real time, they are also subject to limitations. First, FRET 
sensors, because they use two fluorescent proteins of different wavelengths, they occupy 
a large amount of the visible spectrum, making multiplexing difficult. However, imaging 
two FRET sensors simultaneously in the same cell has been demonstrated. In one 
approach, a long-stokes shift FP, LSS-mOrange as a donor is one biosensor, while a cyan 
donor is used in the other sensor, so that the same wavelength can excite donors with 
spectrally distinct emissions46. In another approach, two biosensors with the same or 
spectrally similar donors are paired with spectrally distinct acceptors are used. For 
example, a cyan-yellow and a cyan-red has been shown to co-image cAMP and PKA 
dynamics in the same cell47. To image three FRET biosensors simultaneously in the same 
cell, application of a complex model of 3-D spectral unmixing has been demonstrated48. 
However, for most applications of multiplexed signaling measurements in live cells, 
single-color sensors are required. 
 In addition to limits on the multiplexing of genetically encodable biosensors, this 
approach is inherently limited in spatial resolution by the diffraction of visible light in 
fluorescence microscopy. The theoretical limit of spatial resolution for light microscopy 
is dependent on the wavelength of light and the numerical aperture of the condenser and 
objective and for most applications and is roughly 250 nm. Therefore, to observe 
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signaling microdomains with features smaller or spaced closer than 250nm, new 
molecular tools are needed to be compatible with super-resolution techniques49. 
 
Histone Methylation and the Spatial Organization of the Nucleus 
While phosphorylation is a key player in signal transduction pathways, PTMs also 
play a critical role in epigenetic regulation of the genome. This process is critical for 
establishing and maintaining cell-type identity by silencing the transcription of certain 
genes and enhancing expression of others. Genomic DNA wraps around an octomer of 
histone proteins, composed of two copies of histones H2A, H2B, H3, and H4, forming a 
nucleosome, which functions as a bead in the bead on a string chromatin structure. 
Another histone, H1, sits on top of the structure and participates in the formation of 
higher order structuring. The largely unstructured N- and C-terminal tails of histones 
protrude from the nucleosome and serve as regulators of DNA packing. Histone tails can 
facilitate binding with other nucleosomes or linker DNA regions as well as mediating the 
binding of other non-histone proteins to the chromatin. These processes are highly 
dependent on a large number of PTMs, such as methylation, acetylation, phosphorylation, 
ubiquitination, and citrullination at specific sites on the histone tails. These PTMs work 
together to provide a highly complex means of regulating chromatin structure and 
consequently gene expression.  
 
Chromatin Structure and Organization 
Loosely packaged chromatin called euchromatin maintains a beads on a string 
structure, with plenty of space to allow for transcription factor and polymerase binding, 
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allowing transcription. However, for more silenced parts of the genome, the chromatin 
adopts a more highly condensed form called heterochromatin that is transcriptionally 
inactive. Arranging nucleosomes in a more compact configuration sterically occludes the 
binding of critical DNA-binding proteins essential for transcription, such as transcription 
factors and polymerase. Some regions of the genome, especially in gene-poor, repeat-rich 
areas, are found in heterochromatin in all cell-types, called constitutive heterochromatin. 
On the other hand, other regions are only in heterochromatin form in certain cell types, 
called facultative heterochromatin. Heterochromatin is found principally at telomeres, 
around the centromeres  (pericentromeric) as well in small domains interspersed among 
euchromatin50. Its distribution within the nucleus depends highly on cell-type, but often is 
found on the nuclear periphery, as perinucleolar domains, or as large bodies within the 
nucleus50. These masses of heterochromatin in the interior of the nucleus include compact 
pericentromeric bodies as well larger bodies called chromocenters. 
 
The Histone Code 
 Whether or not a segment of DNA is organized into euchromatin or 
heterochromatin depends largely on the interplay of PTMs on the histone tails. These 
PTMs may change the electric charge on the protein and in this way block particular 
electrostatic interactions. For example, acetylation of lysine residues on the histone tail 
neutralize the positive charge of the lysine, which weakens binding with DNA and other 
histones51. Likewise, phosphorylation adds negative charge to the histone tails and thus 
influences chromatin structure52.  
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In addition to altering the electrostatics, PTMs on the histone tails also serve as 
docking sites for other proteins that regulate chromatin configuration. For example, 
lysine methylation recruits several chromatin factors, non-histone proteins that affect 
chromatin structure, often through enzymatic manipulation of PTMs or formation of 
complexes. Several protein domains mediate this recruitment, such as the Tudor “royal” 
family of domains (Tudor, chromodomains, PWWP, and MBT domains) as well as PHD 
fingers52. While acetylation generally favors enhancing transcription, histone methylation 
at particular sites has been known to either enhance or repress transcription in a site-
specific way. However, the precise interplay of influences from each histone 
modification and how they work together to determine chromatin structure is exceedingly 
complex and only partially understood.  
 
Histone 3 Tri-Methylated Lysine 9 (H3K9me3)  
 The tri-methylation of H3 at lysine 9 (H3K9me2/3) is a strong and well-studied 
marker of constitutive heterochromatin, especially when found in at pericentrosomic 
regions53. Two lysine methyltransferases, SUV39H1/2, are responsible for di- and tri- 
methylation of H3K9. These methyltransferases contain a chromodomain, allowing them 
to dock on the H3K9me3 PTM; however the mechanism of their original recruitment to 
pericentrosomic regions is unknown53. H3K9me3 also causes serves as a docking site for 
chromobox protein homolog 1 (CBX1), a member of the heterochromatin protein 1 
(HP1) family54. The recruitment of CBX1 requires both H3K9me3 as well as binding to 
SUV39H55. CBX1 then recruits a large number of transcription regulators and chromatin 
modifying proteins54. Studies of the spatial distribution of H3Kme3 show that they exist 
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in large (100 nm to 1µm sized) nanodomains, enriched at the nuclear periphery, around 
the nucleolus, and in the nucleoplasm56.  
 
Overview of Dissertation 
 This dissertation presents three novel technologies that expand our ability to study 
the spatial and temporal dynamics of PTMs in real time in live cells using genetically 
encodable fluorescent reporters. In Chapter 2, we present a suite of signaling activity 
reporters, called FLAREs, designed for multiplexed activity imaging. We then present 
another suite of signaling activity reporters in Chapter 3, called FLINC biosensors, which 
allow for monitoring of kinase activity at a sub-diffraction spatial resolution. Finally, in 
Chapter 4, we describe a novel genetically encodable histone modification probe for the 
H3K9me3 modification, to allow for sub-diffraction resolution maps of constitutive 
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Genetically encoded fluorescent biosensors have revolutionized the study of 
signal transduction by enabling the real-time tracking of signaling activities in live cells. 
Investigating the interaction between signaling networks has become increasingly 
important to understanding complex cellular phenomena, necessitating an update of the 
biosensor toolkit to allow monitoring and perturbing multiple activities simultaneously in 
the same cell. We therefore developed a new class of fluorescent biosensors based on 
homo-FRET, called FLuorescence Anisotropy REporters (FLAREs), which combine the 
multiplexing ability of single-color sensors with a quantitative, ratiometric readout. Using 
an array of color variants, we were able to demonstrate multiplexed imaging of three 
activity reporters simultaneously in the same cell. We further demonstrate the 




Genetically encoded biosensors have revolutionized the study of cell signaling by 
allowing the real-time monitoring of signaling activities, such as enzymatic activity or the 
release of second messengers, in live cells. They are therefore critical tools for 
uncovering the precise spatial and temporal regulation of signal transduction cascades. 
These biosensors can be divided into two broad classes: single-color and ratiometric. 
Single-color sensors, with an intensiometric activity readout, only occupy a single color 
channel, allowing for more flexibility in multiplexed imaging experiments. However, 
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they are sensitive to variations in probe concentration caused by changing expression 
levels or cell shape, as well as differences in imaging conditions, such as illumination 
intensity and focus. On the other hand, sensors with a ratiometric readout, such as those 
based on Förster Resonance Energy Transfer (FRET), cancel out many of these variations, 
enabling quantitative measurements of second messenger concentrations and better 
comparisons between experiments. However, the requirement for two distinct color 
channels limits their application in multiplexed imaging. 
 We therefore aimed to develop sensors that only occupy a single channel while 
still cancelling out the effects of varying imaging conditions and probe concentrations. 
Hence, rather than use the emission ratio between the FRET and donor channels, we 
instead used the loss of polarization of emitted light as a readout for FRET between two 
fluorescent proteins (FPs). Because this approach does not require the donor and acceptor 
to have distinct emission wavelengths, it can be used for either hetero-FRET (e.g., 
between different chromophores) or homo-FRET (e.g., between identical chromophores). 
Homo-FRET measurements have been useful for detecting protein clustering and protein 
oligomerization in live cells1,2,3, but only recently has the possibility of using homo-
FRET in biosensor designs been explored4,5. Here we describe the development of a 
panel of single-color, genetically encodable biosensors based on homo-FRET for 
detecting kinase activity and second messenger dynamics. We call these sensors 





Results and Discussion  
Development of a Family of FLARE PKA Sensor 
 To create our FLARE probes, we adapted existing FRET-based biosensors for 
homo-FRET measurements by replacing the traditional FRET pair with two FPs of the 
same color. The resulting biosensors include a molecular switch, which changes 
conformation in the presence of a particular biochemical activity, flanked by two 
spectrally similar FPs at the N- and C-termini. Changes in the conformation of the 
molecular switch, and thus the biochemical activities under study, are then monitored by 
observing the fluorescence anisotropy of the sensor using fluorescence polarization 
microscopy, with increased anisotropy corresponding to a lower-FRET state of the sensor, 
similar to the effect of increasing the intramolecular distance between the FRET pair 
(Figure 2.1).  
To develop a Protein Kinase A (PKA) activity FLARE, the molecular switch from 
A Kinase Activity Reporter 4 (AKAR4)6,7, composed of an FHA1 domain and PKA 
substrate (Figure 2.2a), was flanked between two FPs of the same color. The FHA1 
domain binds to the PKA substrate when the latter is phosphorylated, altering the 
conformation of the molecular switch and leading to a change in FRET between the 
flanking homo-FRET pair. To test the effect of FP circular permutation on these 
biosensors, we developed two FLARE-AKAR variants based on the yellow FP mVenus: 
one in which the C-terminal FP was circularly permuted at position 172 (cp172Venus), 
consistent with the hetero-FRET AKAR4 sensor, and one without circular permutation. 
We expressed mVenus-cp172Venus FLARE-AKAR in HEK293T cells and captured a 
time-course using fluorescence polarization microscopy. Following PKA activation using 
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a cocktail of 50 µM forskolin (Fsk), an adenylyl cyclase activator, and 100 µM 3-
isobutyl-1-methylxanthine (IBMX), a general phosphodiesterase inhibitor, the anisotropy 
decreased from 0.29±0.003 to 0.26±0.003, a decrease of 0.028±0.001 (N=44 (mean 
anisotropy of individual cells [biological replicates], unpaired, two-tailed t-test, 
p<0.0001), with the kinetics of the decrease matching those observed with AKAR4 
(Figure 2.2b, Figure 2.3a). The yellow variant without the circular-permutation in the C-
terminal FP showed slightly reduced changes in anisotropy upon stimulation with 
Fsk/IBMX (Figure 2.2c, Figure 2.3c), consistent with previous observations in hetero-
FRET-based biosensors8,9,10. We observed a slight positive correlation between intensity 
and anisotropy change for Venus-cp172Venus FLARE AKAR; however the expression 
level does not significantly impact the reporting ability of these sensors in general (Figure 
2.4a). The signal-to-noise ratio (SNR) of Venus-cp172Venus FLARE-AKAR was 
calculated to be 32 by dividing the magnitude of the anisotropy change upon maximal 







Figure 2.1 Anisotropy vs. Intramolecular Distance 
Anisotropy measurements of monomer, as well as tandem dimers 
separated by either a long (44 amino acid) or a short (10 amino acid) 
linker, of a). mCerulean3, b). mVenus, and c). mCherry. Data points 
reflect the mean intensity of individual cells (biological replicates). The 



















































































Figure 2.2 Development and Characterization of FLARE AKAR 
a). Schematic of a kinase activity FLARE b). Diagram illustrating domain 
structure of FLARE-AKAR (top). Time-course of mean fluorescence 
anisotropy of Venus-cp172Venus FLARE-AKAR wild type (blue, N=44) 
and kinase insensitive T-to-A mutant (red, N=38) expressed in HEK293T 
cell, stimulated with 50 µM forskolin and 100 µM IBMX at t=0 min, and 
20 µM H-89 at t=24 min (left). Dashed lines above and below represent 
standard error of the mean. Changes in anisotropy upon Fsk/IBMX 
mVenus-cpVenus172 FLARE AKARb









































































 Figure 2.2 (continued) stimulation for both FLARE-AKAR WT and T-
to-A mutant (upper right, two-tailed t-test, p<0.0001), calculated as the 
difference between the mean anisotropy from t=5 min to t=7.5 min and the 
mean anisotropy of the baseline before drug addition. The mean for each 
is shown, with the error reflecting the standard error of the mean. 
Representative anisotropy pseudocolor image before Fsk/IBMX 
stimulation (t=0 min), after Fsk/IBMX stimulation (t=7.5 min), and after 
inhibition of PKA with H-89 (t=24 min) (lower right) c). Comparison of 
the magnitude of the anisotropy change for different color variants of 
FLARE-AKAR upon stimulation with Fsk/IBMX including Venus-
cp172Venus AKAR (N=44), Venus-Venus FLARE AKAR (N=32), 
EGFP-EGFP FLARE AKAR (N=13), mCh-mCh FLARE AKAR (N=22), 
mCerulean3 FLARE-AKAR (N=10), and mCerulean3-cp173Cerulean 
FLARE-AKAR (N=26). N numbers reflect the mean intensity of 
individual cells (biological replicates). The mean for each is shown, with 
the error reflecting the standard error of the mean. 
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Figure 2.3 Single Cell Traces for FLARE AKAR Variants 
Individual and average traces for FLARE-AKAR variants, including a). 
Venus-cp172Venus AKAR (N=44), b). Venus-cp172Venus FLARE-
AKAR T/A mutant (N=38), c). Venus-Venus FLARE AKAR (N=32), d). 
EGFP-EGFP FLARE AKAR (N=13), e). mCh-mCh FLARE AKAR 
(N=22), f). mCerulean3-mCerulean3 FLARE-AKAR (N=10), and g). 
mCerulean3-cp173Cerulean FLARE-AKAR (N=26). Gray lines are 
individual cell traces, while the red solid line is the average curve. N 
numbers reflect the mean intensity of individual cells (biological 
replicates). Red dotted lines represent the average curve plus or minus 
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Figure 2.4 Signal vs Expression Level for FLARE AKAR  
Scatter plots showing the relationship between the magnitude of the 
anisotropy change after treatment with 50µM forskolin and 100µM IBMX 
and the initial intensity for a). Venus-cp172Venus FLARE AKAR and b). 
mCherry-mCherry FLARE AKAR, in HEK293-T cells. The magnitude of 
the signal was calculated by taking the mean anisotropy from t = 5min to t 
= 7.5 min and subtracting the mean anisotropy of the baseline before drug 
addition. 
  




























 Subsequent control experiments confirmed that this change in anisotropy is 
caused by a change in the FRET state due to the conformational change of the sensor 
upon stimulation of PKA activity. PKA inhibition using 20 µM H-89 led to an immediate 
slope change and increase in anisotropy (Figure 2.2b). On the other hand, a mutant 
version of the biosensor with a threonine-to-alanine (T-to-A) mutation at the 
phosphorylation site showed no change in anisotropy upon PKA stimulation with 
Fsk/IBMX or inhibition with H-89 (Figure 2.2b, Figure 2.3b), suggesting that the 
observed changes in anisotropy were due to phosphorylation  of the PKA substrate.  
Furthermore, isoproterenol, a β-adrenergic agonist, induced FLARE-AKAR responses in 
a dose-dependent manner (Figure 2.5). To further demonstrate that the change in 
anisotropy upon PKA stimulation was due to a change in FRET, we mutated the 
chromophore of the C-terminal cp172Venus in Venus-cp172Venus FLARE AKAR from 
GYG to GGG. We observed that the magnitude of the response to Fsk/IBMX decreased 
to approximately one-third of that of the wild-type sensor (Figure 2.6). The remaining 
response was likely due to intermolecular FRET that occurs when the FHA1 domain of 




Figure 2.5 Venus-cp172 Venus isoproterenol dose response 
HEK293-T cells were transiently transfected with Venus-cp172Venus 
FLARE-AKAR, and stimulated with varying doses of isoproterenol, 
followed by maximal stimulation with 50 µM forskolin and 100 µM 
IBMX. The ratio of the anisotropy decrease following isoproterenol dose 
to that after Forskolin and IBMX stimulation vs. the isoproterenol dose is 
plotted. Error bars reflect the standard error of the mean. 
 
  


































Figure 2.6 Characterization of the chromophore-dead FLARE AKAR 
mutant 
a). Comparison of Venus-cp172Venus FLARE AKAR responses of the 
wild type sensor and a mutant sensor in which the chromophore of the C-
terminal cp172Venus was mutated from GYG to GGG (N=53), expressed 
in HEK293-T cells and treated with 50µM forskolin and 100µM IBMX. b). 
Individual cell traces for Venus-cp172Venus FLARE AKAR (GGG 
mutant). The red curve represents the mean for all the cell traces, with the 









































 In addition to the yellow sensors, we developed a panel of color variants of 
FLARE-AKAR, including EGFP-EGFP, mCherry-mCherry, mCerulean3-mCerulean311, 
and mCerulean3-cp173Cerulean3 versions. All of these variants exhibited a decrease in 
anisotropy in cells treated with Fsk/IBMX; however, the magnitude of the anisotropy 
decrease depended on the choice of FP, with the mVenus-cp172Venus variant having the 
largest response (Figure 2.2c, Figure 2.3). As with the Venus variants, the Cerulean3-
based FLARE-AKAR showed an increased dynamic range with a circularly-permutated 
fluorescent protein at the C-terminal position. mCherry-mCherry FLARE-AKAR, being 
spectrally shifted from the AKAR4 heteroFRET sensor allowed for direct comparison of 
FLARE and heteroFRET sensors within the same cell. As shown in Figure 2.7, changes 
in anisotropy in mCherry-mCherry FLARE-AKAR corresponded with the changes in 
normalized emission ratio in AKAR4, with similar kinetics.  
We furthermore demonstrated the ability of FLARE-AKAR sensors to monitor 
kinase activity at particular subcellular compartments. By fusing Venus-cp172Venus 
FLARE-AKAR to targeting motifs from Lyn kinase and DAKAP1, we were able to 
detect PKA activity at the plasma membrane and outer mitochondrial membrane,  
respectively (Figure 2.8). Moreover, we used untargeted FLARE sensors to detect 
differential PKA activity dynamics in different compartments; diffusable Venus-
cp172Venus FLARE AKAR in HeLa showed that PKA activity has slower kinetics and a 






Figure 2.7 Direct comparison of FLARE and heteroFRET AKAR 
sensor 
mCherry-mCherry FLARE-AKAR and AKAR4 were co-expressed in 
HEK cells, which were stimulated with 50µM forskolin and 100µM IBMX 
at t=0 min (N=74). a). Average anisotropy traces for mCherry-mCherry 





































































































































































































































































































FLARE AKAR and average normalized emission ratio traces are shown 
for AKAR4. The dashed lines above and below the curve represent the 
standard error of the mean. b). Nine representative cell traces showing 






Figure 2.8 Subcellular targeted FLARE-AKARs.  
Average anisotropy traces of Venus-cp172Venus FLARE AKAR 
subcellularly targeted to a) the plasma membrane with the Lyn-kinase 
targeting motif (N=77) b) the mitochondrial membrane with the targeting 
sequence from DAKAP (N=32), expressed in HEK cells stimulated with 
50 µM forskolin and 100 µM IBMX at t=0 min, and 20 µM H89 at t=7.5 
min. Scale bars are 10 µm. Dashed lines above and below the curves 
reflect the standard error of the mean. 
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Figure 2.9  Differential PKA activity kinetics in the cytosol and the 
nucleus 
 a). Comparison of Venus-cp172Venus FLARE AKAR anisotropy 
changes in the cytosol and the nucleus in HeLa cells treated with 50µM 
forskolin and 100µM IBMX (N=19). Dashed lines above and below the 
curves reflect the standard error of the mean. b). Comparison of the time 
for the anisotropy change to peak or plateau in the cytosol and the nucleus 
(two-tailed paired T-test, p=0.0295). c). Comparison of the time for the 
anisotropy change to reach half of the peak (t1/2) in the cytosol and the 
nucleus (two-tailed paired T-test, p=0.0065). d). Comparison of the 
magnitude of the anisotropy change in the cytosol and the nucleus (two-
tailed, paired T-test, p<0.0001). e). Eight representative anisotropy time 













































































































































































































































































Generalizing the FLARE Design to Other Kinase Activity and Activation Biosensors 
To demonstrate the generalizability of FLAREs, we developed a family of single-
color kinase activity or activation reporters in various colors (Figure 2.10). To construct a 
single-color Erk activity biosensor, we replaced the PKA sensor domain from Venus-
cp172Venus FLARE-AKAR with the sensor domain from EKAR-EV, composed of a 
WW domain (PAABD), a flexible EV linker, and an Erk substrate peptide (Figure 
2.10a)12,13. When expressed in HEK293T cells, Venus-cp172Venus FLARE-EKAR-EV 
exhibited a decrease in anisotropy of 0.02±0.001 (N=13) after treatment with 100 ng/mL 
epidermal growth factor (EGF) to activate the MAPK pathway (Figure 2.10a, Figure 
2.11). This response was reversed upon MEK inhibition using 20 µM U0126, and no 
change in anisotropy was observed with a T-to-A mutant sensor. Likewise, we developed 
a panel of PKC activity reporters, called FLARE-CKARs, by flanking a PKC sensor 
domain composed of an FHA1 domain and a PKC substrate14 from a CKAR2 construct 
(Figure 2.12) with mVenus-cp172Venus. We observed an anisotropy decrease of 
0.02±0.001 (N=26) upon activation of PKC with 100 ng/mL phorbol 12-myristate 13-
acetate (PMA) (Figure 2.10b, Figure 2.13). For both FLARE-EKAR (Figure 2.11) and 
FLARE CKAR (Figure 2.13), we likewise repeated this process for various color variants, 
and like the FLARE-AKARs, the sensors based on mVenus exhibited the largest 
responses. Furthermore, a myosin light chain kinase (MLCK) sensor was converted to a 
FLARE by exchanging the cyan FP for mVenus15. Calmodulin (CaM) association with 
the MLCK-CaM binding domain in between the FPs decreases FRET, leading to an 
increase in fluorescence anisotropy upon forced calcium (Ca2+) entry with 30 mM KCl 
(N=13) (Figure 2.10b, Figure 2.14). 
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Figure 2.10  A panel of kinase activity and activation sensors  
a). Domain structure of FLARE-EKAR-EV (above).  Time-course of 
mean fluorescence anisotropy of Venus-cp172Venus FLARE-EKAR-EV 
WT (blue, N=13) and kinase-insensitive mutant (red, N=16) expressed in 
HEK293T cell, with addition of 100 ng/mL EGF at t=0min and 20 µM 
U0126 at t=25min (left). Summary of anisotropy changes (upper right, 
WT
TA
a mVenus-cpVenus172 FLARE EKAR-EV
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Figure 2.10 (continued) two-tailed t-test, p<0.0001), calculated as the 
difference between the mean anisotropy from t=10 min to t=15 min and 
the mean anisotropy of the baseline before drug addition. The mean is 
shown, with the error reflecting the standard error of the mean. 
Representative anisotropy pseudocolor image before EGF stimulation (t=0 
min), after EGF stimulation (t=25 min), and after inhibition of MEK with 
U0126 (t=47.5 min) (lower right). b). Domain structure of FLARE-CKAR 
(above). Time-course of fluorescence anisotropy of Venus-cp172Venus 
FLARE-CKAR WT (blue, N=26) and kinase-insensitive mutant (red, 
N=119) with addition of 100 ng/mL phorbol 12-myristate 13-acetate 
(PMA) at t=0min.  Summary of response magnitudes (upper right, two-
tailed t-test, p<0.0001), calculated as the difference between the mean 
anisotropy from t = 10 to t = 11.33 min and the mean anisotropy of the 
baseline before drug addition. The mean is shown, with the error reflecting 
the standard error of the mean. Representative anisotropy pseudocolor 
image before PMA addition (t=0 min) and after PMA addition (t=15 min). 
c). Domain structure of FLARE-MLCK (top). Anisotropy time course of a 
representative REF52 cell expressing YFP-Venus FLARE-MLCK treated 
with 30 mM KCl at t=0 (N=13, blue), or vehicle control (N=10). Summary 
of anisotropy changes, calculated as the mean difference between the 
anisotropy at t = 0.333 min and the anisotropy of the baseline, before KCl 
addition (upper right, two-tailed t-test, p<0.0001). Representative 
pseudocolor anisotropy images before and after KCl treatment (lower 
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Figure 2.10 (continued) right). Dashed lines above and below time course 
traces reflect the standard error of the mean. FP, fluorescent protein; CaM 




Figure 2.11 FLARE-EKAR Characterization 
a). Individual (gray) and average (red) cell traces for Venus-cp172Venus 
FLARE EKAR (N=13), expressed in HEK293T cells and treated with 100 
ng/mL epidermal growth factor (EGF) at t=0 min and the MEK inhibitor 
U0126 at t=25 min. b). Individual (gray) and average (red) cell traces for 
Venus-cp172Venus FLARE EKAR with a threonine-to-alanine (T-to-A) 
at the phosphorylation site (N=16), expressed in HEK293T cells and 
treated with 100 ng/mL epidermal growth factor (EGF) at t=0 min and the 
MEK inhibitor U0126 at t=25 min.  c). A summary of anisotropy changes 
for various color-variants of FLARE-EKAR, upon stimulation with 100 
ng/mL EGF. The magnitude of the signal was calculated by taking the 
mean anisotropy from t = 10min to t = 15 min and subtracting the mean 
anisotropy of the baseline before drug addition.  
  



























































Figure 2.12 Characterization of the CKAR2 hetero-FRET sensor.  
a). Comparison of CKAR1 and CKAR2 domain structures. b). 
Comparison of FRET responses of CKAR1 and CKAR2 expressed in 
HeLa cells to Protein Kinase C (PKC) stimulation with 50 ng/mL phorbol 
12-myristate 13-acetate (PMA) as well as PKC inhibition with 1 µM 
Gö6983. Curves here represent mean curves from one representative 
experiment with biological replicates N=7 for CKAR1 and N=4 for 
CKAR2; the experiment was repeated three times. 
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Figure 2.13 FLARE CKAR characterization.  
a). Individual (gray) and average (red) cell traces for Venus-cp172Venus 
FLARE CKAR (N=26), expressed in HEK293-T cells treated with 
50ng/mL PMA at t=0 min. Dotted lines above and below the curves reflect 
the standard error of the mean. b). Individual (gray) and average (red) cell 
traces for the kinase-inactive mutant of Venus-cp172Venus FLARE 
CKAR (TA mutant) (N=119), expressed in HEK293-T cells treated with 
50ng/mL PMA at t=0 min. c). A summary of anisotropy changes for 
various color-variants of FLARE-ICUE in HEK293T cells upon 
stimulation with 50ng/mL PMA. The magnitude of the signal was 
calculated by taking the mean anisotropy from t = 10 min to t = 11.33 min 
and subtracting the mean anisotropy of the baseline before drug addition. 

























































Figure 2.14 Characterization of FLARE MLCK 
a). Individual (gray) and average (red) cell traces for FLARE-MLCK 
(N=13) with KCl added at t=0 min (N=13). b). Individual (gray) and 
average (red) cell traces for FLARE-MLCK with vehicle only added at 
t=0min (N=10). The dashed lines above and below the red curve reflect 
the standard error of the mean. The magnitude of the signal was calculated 
by taking the Δanisotropy at t = 0.33 min and subtracting the mean 
Δanisotropy of the baseline before drug addition. 
  





























Developing FLARE Second-Messenger Biosensors 
In addition to biosensors for monitoring enzymes, we also developed FLAREs for 
monitoring second messenger dynamics (Figure 2.15a). We developed a Ca2+ FLARE by 
utilizing the sensor domain from the Cameleon family of biosensors, composed of CaM 
and the Ca2+/CaM-binding peptide M138,16. When expressed in HEK293T cells, Venus-
cp172Venus FLARE-Cameleon exhibited a decrease in anisotropy of 0.03±0.002 (N=10) 
upon addition of 1 µM ionomycin and 5 mM CaCl2, with the Venus-Venus, mCerulean3-
mCerulean3, and mCherry-mCherry versions also showing detectable responses (Figure 
2.15b, Figure 2.16a,b). The mVenus-based FLARE sensors tend to show larger dynamic 
ranges for a variety of FLARE sensors than mCerulean3 or mCherry variants, likely due 
to the superior extinction coefficient and quantum yield of mVenus, which make it a 
good FRET donor and acceptor. We further demonstrated the ability of Venus-
cp172Venus FLARE Cameleon to detect submaximal responses by monitoring calcium 
transients in histamine-stimulated HeLa cells (Figure 2.16c). In order to determine the 
dissociation constant and Hill coefficients, we purified Venus-cp172Venus Cameleon and 
measured the fluorescence anisotropy in solutions of known free Ca2+ concentration at 
different temperatures (Figure 2.17). The resulting parameters are in good agreement 
with other Cameleon sensors8. Furthermore, we developed another calcium FLARE 
sensor, based on D1-ER17, with a sensitivity appropriate for calcium monitoring in the 
ER. The anisotropy decreases upon increasing calcium concentration and increases when 
calcium is depleted from the ER upon treatment with thapsigargin (Figure 2.18). In 
addition to Ca2+, we developed a FLARE to detect intracellular cAMP based on the ICUE 
family of sensors, in which a conformational change in the cAMP effector EPAC leads to 
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a decrease in FRET efficiency in the presence of cAMP18 (Figure 2.15a). When expressed 
in HEK293T cells, the fluorescence anisotropy of Venus-cp172Venus FLARE-ICUE 
increased by 0.02±0.001 (N=40) upon stimulation with Fsk/IBMX (Figure 2.15c, Figure 
2.19).   
 
Multiparameter Imaging with FLARE Biosensors 
The fact that FLAREs only occupy a single color channel and are highly 
generalizable for different biosensors, as well as color variants, highlights their utility for 
multiplexed imaging applications. While multiplexing of hetero-FRET sensors is 
generally limited to two probes19,20, we demonstrate that FLAREs can facilitate co-
imaging of three biosensors simultaneously. We co-expressed mCherry-mCherry 
FLARE-AKAR, Venus-cpVenus FLARE-EKAR-EV, and mCerulean3-mCerulean3 
FLARE-Cameleon in HEK293T cells and acquired a time-course with sequential 
treatment using Fsk/IBMX, EGF, and thapsigargin. Clear and distinct decreases in 
anisotropy were observed in the red channel after Fsk/IBMX treatment, in the yellow 
channel after EGF stimulation, and in the cyan channel after thapsigargin treatment, 
corresponding to an increase in PKA activity, Erk activity, and intracellular Ca2+, 








Figure 2.15 Design and characterization of FLARE second 
messenger sensors. 
 a). Schematic of FLARE ICUE cAMP second messenger sensor b). 
Domain structure of FLARE-Cameleon (top). Time-course of mean 
fluorescence anisotropy of Venus-cp172Venus FLARE-Cameleon 
(N=10) with addition of 1 µM ionomycin and 5 mM CaCl2. Summary of 






































































Figure 2.15 (continued) anisotropy changes after 1 µM ionomycin and 
5 mM CaCl2 (upper right) calculated as the difference between the mean 
anisotropy from t= 5min to t = 7.5 min and the anisotropy of the baseline 
before drug addition  Representative anisotropy pseudocolor image 
before and after 1 µM ionomycin and 5 mM CaCl2 addition. c). Domain 
structure of the cAMP sensor FLARE-ICUE (top). Time-course of mean 
fluorescence anisotropy of Venus-cp172Venus FLARE-ICUE (N=40) 
with addition of 50 µM forskolin and 100 µM IBMX at t=0 (left). 
Summary of anisotropy changes after 50 µM forskolin and 100 µM 
IBMX with respect to baseline (upper right), calculated as the difference 
between the mean anisotropy from t= 5min to t = 7.5 min and the 
anisotropy of the baseline before drug addition.  Representative 
anisotropy pseudocolor image before (t=0 min) and after (t=7.5) 
stimulation with Fsk/IBMX (lower right). Dashed lines above and below 





Figure 2.16 Characterization of FLARE Cameleon. 
a). Individual (gray) and average (red) cell traces for Venus-cp172 
FLARE Cameleon (N=10). b). A summary of anisotropy changes for 
various color-variants of FLARE-Cameleon in HEK293T cells upon 
stimulation with 1 µM ionomycin and 5mM calcium chloride. The mean 
for each is shown, with the error reflecting the standard error of the 
mean. The magnitude of the signal was calculated by taking the mean 
anisotropy from t = 5 min and t = 7.5 min and subtracting the mean 
anisotropy of the baseline before drug addition. c). Average anisotropy 
trace for Venus-cp172Venus FLARE-Cameleon expressed in HeLa cells 
upon stimulation with histamine (100 µM). Dotted lines above and 
below the curves reflect the standard error of the mean. 

































































Figure 2.17 In vitro calibration of purified Venus-cp172 FLARE-
Cameleon. 
Anisotropy vs. calcium concentration calibration curves of purified 
Venus-cp172Venus Cameleon for a). 25°C b). 32°C, and c). 37°C. 
 
 

































a b c 25°C 32°C 37°C 
Kd =250 nM 
n=2.4 
Kd =240 nM 
N=1.7 





Figure 2.18 Characterization of CFP FLARE-D1ER 
a). Schematic of the ER calcium sensor. b).  REF52 cells expressing 
CFP FLARE D1ER were permeabilized using 5 µM ionomycin and 
equilibrated with 3 mM EGTA to remove Ca2+ or the indicated Ca2+ 
concentration. Fluorescence anisotropy values were normalized to the 
Ca2+ free condition. Statistical significance was assessed using an 
ANOVA and Tukey Multiple comparison test (*** p < 0.001, **** p ≤ 
0.0001). c) REF52 cells expressing CFP FLARE D1ER were treated 
with thapsigargin (1 uM, 5 min),  to reduce ER Ca2+ levels (N=8, ** p < 
0.01 by t-test). The mean for each of the above is shown, with the error 

























































Figure 2.19 Individual Cell Traces for FLARE-ICUE 
 a). Individual (gray) and average (red) cell traces for Venus-cp172 
FLARE-ICUE (N=40). Dashed lines above and below the average curve 
reflect the standard error of the mean. 
  

















Figure 2.20 Multiparameter Imaging with FLAREs 
a). Time-course of a representative HEK293T cell co-expressing 
mCherry-mCherry FLARE-AKAR, mVenus-cp172Venus FLARE-
EKAR-EV, and mCerulean3-mCerulean3 FLARE-Cameleon, with 50 
µM forskolin/100 µM IBMX added at t=0min, 100 ng/mL EGF at 












































































































Figure 2.20 (continued) t=7.5min, and 1 µM thapsigargin added at 
t=32.5min (N=17). b). Anisotropy response of a representative MIN6 
cell co-expressing Cerulean3-Cerulean3 FLARE-Cameleon and Venus-
cp172Venus FLARE-ICUE, showing robust oscillations after 
stimulation with TEA at t=0min (N=19). c). Venus-cp172Venus 
FLARE-Cameleon anisotropy time-course in REF52 cells co-
expressing the sensor and either mCherry-tagged humanized channel 
rhodopsin2 (blue-curve) or mCherry alone (red-curve), with periodic 
illumination with 455nm light (indicated by cyan shading). d). Purified 
mVenus and mCherry proteins were placed in separate capillary tubes 
and imaged with 855 nm and 1200 nm two-photon excitation. Plasmids 
encoding Venus-cp172Venus FLARE-Cameleon and mCherry-
mCherry FLARE-AKAR were electroporated into the skeletal muscle 
of the foot of a live mouse for in vivo imaging. Below are Z-stack 
projections of skeletal muscle co-expressing these two sensors, excited 
with 855 nm (left) and 1200 nm (right) light. e). Electrical stimulation 
decreased fluorescence anisotropy in the 855nm channel, consistent 
with increased cytoplasmic Ca2+ (left) (two-tailed T-test, p=0.0037). 
Intraperitoneal injection of isoproterenol activates mCherry-mCherry 
FLARE AKAR (two-tailed T-test, p=0.0239), as indicated by decreased 
anisotropy in the 1200nm channel (right). The mean for each is shown, 
with the error reflecting the standard error of the mean. 
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Figure 2.21 Average and Individual Traces for Three-Color FLARE 
Imaging 
a). Average cell traces for mCherry-mCherry FLARE-AKAR, Venus-
cp172Venus FLARE-EKAR, and mCer3-mCer3 FLARE Cameleon, 
expressed in HEK293T cells, and stimulated with 50 µM forskolin and 
100 µM IBMX at t=0min, 100 ng/mL EGF at t=7.5 min, and 1 µM 
thapsigargin at t=32.5min. (Dashed lines reflect the standard error of the 

















































































































































































































































































































 We further aimed to show that FLARE sensors can be used to monitor multiple 
signaling activities simultaneously in different cellular contexts. For example, mCer3-
mCer3 FLARE Cameleon, co-imaged with other FLARE sensors in HeLa cells, can 
detect calcium responses to physiologically relevant stimulation conditions, such as 
histamine (Figure 2.22). Additionally, when mCer3-mCer3 FLARE AKAR was co-
imaged with Venus-cp172Venus cameleon in HEK293-T cells, activation of the β-
adrenergic with isoproterenol led to a transient decrease in anisotropy in the cyan-channel 
(Figure 2.23). Furthermore, we used FLAREs to study the cAMP-Ca2+ oscillatory circuit 
in pancreatic β-cells. MIN6 β-cells were transiently transfected with Venus-cp172Venus 
FLARE-ICUE and mCerulean3-mCerulean3 FLARE-Cameleon to simultaneously 
monitor cAMP and Ca2+ dynamics, respectively (N=19). We observed clear fluorescence 
anisotropy oscillations in both channels following stimulation with 20 mM 
tetraethylammonium chloride (TEA) (Figure 2.20b, 2.24). Ca2+ and cAMP exhibit 
synchronized oscillations, with Ca2+ increases corresponding to cAMP decreases, 
consistent with previous findings21,22. These data demonstrate that even the lower-signal 
mCerulean3-based FLARE sensors can be used under sub-maximal and physiologically 




Figure 2.22 Multiparameter FLARE imaging of PKA, Erk and 
calcium, with histamine-induced calcium stimulation 
Average cell traces for mCherry-mCherry FLARE-AKAR, Venus-
cp172Venus FLARE-EKAR, and mCer3-mCer3 FLARE Cameleon, 
expressed in HeLa cells, and stimulated with 50 µM forskolin and 100 
µM IBMX at t=0min, 100 ng/mL EGF at t=7.5 min, and 100 µM 
histamine at t=32.5min (N=11). (Dashed lines reflect the standard error 
of the mean). In the cyan channel, transient decreases in anisotropy can 
be observed both after both EGF and histamine stimulation. b). 









































































































































































































Figure 2.23 Two-color FLARE Imaging of PKA and Calcium with 
Isoproterenol Stimulation of PKA 
a). Average cell traces for mCerulean3-mCerulean3 FLARE-AKAR, and 
mVenus-cp172Venus FLARE Cameleon, expressed in HEK293-T cells, 
and stimulated with 100 nM isoproterenol at t=0min and 1 µM 
thapsigargin at t=40 min (N=28). (Dashed lines reflect the standard error 
of the mean). b). Representative cell anisotropy traces for above 
experiment. 

















































































































































Figure 2.24 Monitoring calcium and cAMP oscillations in pancreatic 
beta cells. 
Additional cell traces for mCer3-mCer3 FLARE-Cameleon and Venus-
cp172Venus ICUE, coexpressed in Min6 cells, showing out of phase 


















































































































































































































































































































































































In addition to multiplexed biosensor imaging, the fact that FLARE sensors occupy 
only a single color channel also permits simultaneously perturbing and monitoring 
biochemical activities using optogenetics and FLAREs, respectively. We coexpressed an 
mCherry-tagged, ER-targeted channelrhodopsin2 (hChR2)23,24,25, a light-gated calcium 
ion channel, with Venus-cp172 FLARE-Cameleon in REF52 cells, a rat embryonic 
fibroblast cell line. Illumination with blue light produced an immediate decrease in 
anisotropy, corresponding to an increase in intracellular Ca2+ (Figure 2.20c, Figure 2.25). 
Control cells lacking hChR2 expression showed no change in anisotropy in the yellow 
channel.  
In vivo, two-photon imaging of FLAREs was tested using a skeletal muscle 
preparation (Figure 2.20d,e). Exclusive excitation of mVenus (855 nm) or mCherry 
1200 nm) was verified by imaging capillary tubes filled with recombinant proteins 
(Figure 2.20d). Plasmids encoding Venus-cp172Venus FLARE-Cameleon and mCherry 
FLARE-AKAR sensors were electroporated into the flexor digitorum brevis muscle of a 
live mouse26, 27. Administration of an electrical current stimulated a rise in intracellular 
Ca2+ concentration, as indicated by a decrease in FLARE-Cameleon anisotropy, 
independent of changes in FLARE-AKAR anisotropy (Figure 4e). Activation of AKAR 
was then induced by intraperitoneal injection of isoproterenol (0.5 mg/kg). Thus, 





Figure 2.25 Individual and Average Cell Traces of FLARE AKAR 
Coexpressed with hChR2-ER 
Individual (gray) and average (red) cell traces for Venus-cp172Venus 
FLARE AKAR co-expressed with hChR2-ER, with intermittent exposures 
to 455nm light (N=11). Dashed lines reflect the standard error of the mean. 
  













 We have demonstrated that FLAREs are a highly generalizable, accessible 
platform for creating single-color sensors to detect biochemical activities in individual 
cells in real time. Their ratiometric readout allows for fluctuations in light intensity and 
probe concentration to be cancelled out, permitting quantitative measurements of 
intracellular concentrations. We showed that these sensors have an SNR of 3-32 (Table 
2.1) and a dynamic range comparable with first-generation FRET sensors28,29. Future 
development and optimization should further enhance their performance.  We 
demonstrated that current FLAREs are already useful for multiplexed imaging 
applications. They can also be used in conjunction with optogenetic tools to enable all-
optical interrogation of cellular regulation, and for intravital two-photon imaging to 
facilitate studies in tissues and living animals. FLAREs, by allowing researchers to 
monitor multiple activities within the same cell, as well as to both monitor and 
optogenetically perturb activities in the same cell, could be used to study the how the 
spatiotemporal regulation of biochemical activities in highly integrated pathways allows a 




Sensor Signal to Noise Ratio (± SEM) 
Venus-cp172Venus FLARE AKAR 32 ± 2.0 (N=32) 
mVenus-mVenus FLARE AKAR 10 ± 1.6 (N=32) 
EGFP-EGFP FLARE AKAR 6 ± 0.6 (N=32) 
mCherry-mCherry FLARE AKAR 14 ± 1.5 (N=22) 
mCerulean3-mCerulean3 FLARE AKAR 3 ± 0.5 (N=10) 
mCerulean3-cp173 Cerulean3 FLARE AKAR  5 ± 0.3 (N=26) 
Venus-cp172Venus FLARE EKAR 17 ±  3.1 (N=8) 
mCherry-mCherry FLARE EKAR 4 ± 0.8 (N=10) 
mCerulean3-mCerulean3 FLARE EKAR 9±2.3 (N=9) 
Venus-cp172Venus FLARE CKAR 27 ± 3.3 (N=26) 
mCherry-mCherry FLARE CKAR 14 ± 3.0 (N=8) 
mCerulean3-mCerulean3 FLARE CKAR 9 ± 1.7 (N=6) 
FLARE-MLCK 8 ± 0.8 (N=13) 
Venus-cp172Venus FLARE Cameleon 19 ± 4.8 (N=10) 
mCherry-mCherry FLARE Cameleon 5 ± 0.8 (N=23) 
mCerulean3-mCerulean3 FLARE Cameleon 9 ± 1.5 (N=11) 
Venus-cp172 Venus FLARE ICUE 19 ± 1.2 (N=40) 
 






Materials and Methods 
Plasmid and Construct Construction 
Cloning was performed using the pRSET-B vector using typical molecular 
cloning methods using polymerase chain reaction (PCR) with Phusion polymerase (New 
England Biolabs), restriction enzyme digestion, and ligation with T4 DNA ligase. To 
clone Venus-cp172Venus FLARE, AKAR4 was sub-cloned from a modified pCDNA3 to 
pRSET-B between the BamHI and EcoRI restriction enzyme sites. mVenus was then 
PCR amplified with primers encoding a BamHI site at the 5’ end and an SphI site at the 3’ 
end, and the resulting PCR product was digested with BamHI and SphI and ligated to 
pRSET-B AKAR4 digested with BamHI and SphI, with the mCerulean1 gene removed. 
Venus-cp172Venus FLARE AKAR was then sub-cloned back into a modified pCDNA3 
vector using the BamHI and EcoRI sites. Other color variants were created by replacing 
the genes for the fluorescent proteins in other FLARE AKAR variants in pRSET-B, 
either between the BamHI and SphI sites for the N-terminal fluorescent protein, or SacI 
and EcoRI for C-terminal fluorescent proteins. Finalized constructs intended for 
mammalian expression were then sub-cloned into a modified pcDNA3 expression vector 
between the BamHI and EcoRI sites. FLARE variants of other sensors were created by 
amplifying the molecular switch from EKAR-EV, CKAR2, Cameleon and ICUE3 with 
primers encoding the SphI and SacI sites, digesting the PCR product with SphI and SacI 
enzymes, and ligating them to the relevant pRSET-B FLARE AKAR plasmid digested 
with SphI and SacI to remove the domains involved in the molecular switch for FLARE 
AKAR. The final constructs were then subcloned into a modified pCDNA3 expression 
vector between the BamHI and EcoRI sites. Targeted versions of the sensors were created 
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either by PCR amplifying the sensor with primers containing the targeting sequence and 
ligating it to the pCDNA3 expression vector between BamHI and EcoRI, or by 
subcloning the construct into a plasmid already containing the targeting sequence. N-
terminal targeting sequences were placed between HindIII and EcoRI, and C-terminal 
targeting sequences between EcoRI and XbaI. All cloning steps were performed using 
DH5α strain of E. coli.   
The threonine to alanine mutants for Venus-cp172Venus FLARE AKAR and 
FLARE EKAR were created by performing site-directed mutagenesis using a standard 
single-primer PCR-based protocol. The threonine to alanine mutant for Venus-
cp172Venus FLARE CKAR, as well as the chromophore-dead variant of Venus-
cp172Venus FLARE AKAR, was created using Gibson assembly, amplifying the 
appropriate fragment with a primer containing the desired mutation.   
The YFP MLCK FLARE sensor was created by replacing the CFP portion of an 
existing two color sensor15,30 with a PCR amplified mVenus fragment flanked by XhoI 
and AgeI restriction sites. Moreover, the coding sequence for the CFP D1 ER sequence 
was manufactured by Genewiz. The sensor consists of two oxmCer3 proteins 
(https://www.ncbi.nlm.nih.gov/pubmed/26158227) flanking the D1 ER calcium sensing 
domains17 and a C-terminal KDEL ER retention sequence.  
 
Cell Culture and Transfection 
HEK293-T and HeLa cells cells were maintained using Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin. Cells were seeded onto a 35-mm glass-bottom imaging dish and 
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incubated at 37°C with 5% ambient carbon dioxide. HEK293-T, HeLa, Min6, and REF-
52 cell lines were maintained separately from other cells and were screened regularly to 
confirm the absence of mycoplasma contamination using Hoechst staining. As the origin 
of the cells was not central to the nature of these experiments, we did not further validate 
the identity of the cell lines. Cells were transfected using Lipofectamine 2000 
(Invitrogen), Polyjet (SignaGen), or calcium phosphate and incubated for 12-48 hours 
before imaging. The growth media was removed immediately before imaging, and the 
cells were washed two or more times with Hanks Balanced Salt Solution (HBSS) buffer 
with glucose at room temperature. The cells were imaged in HBSS buffer with glucose at 
either room temperature or 37°C. 
 
Fluorescence Polarization Microscopy 
Widefield images were collected using an Zeiss AxioObserver equipped for 
fluorescence polarization microscopy, using one of two setups. In the first setup, a wire 
grid polarizer (Meadowlark Optics) was placed in the excitation pathway between the 
LED illuminators and reflector turret containing filter cubes specific for CFP (Zeiss), 
YFP (Zeiss), and mCherry (Semrock). Images were generally collected using a 20× 0.75 
NA objective lens. Polarizations parallel and perpendicular to the excitation polarizations 
were separated using Optical Insights Dual-View using their polarization splitting module. 
Both images were simultaneously collected in a single image collected by a water-cooled 
Orca-R2 (Hamamatsu). In the second setup, a polarizer (Chroma) was placed in the 
excitation pathway between the xenon arclamp and the excitation filters. Images were 
collected using a 20× 0.45 NA objective lens. Polarizations were separated using an 
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Opto-Split II LS image splitter, with two wire grid polarizers (Meadowlark) oriented 
parallel and perpendicular to the excitation polarizer. Images of both polarizations were 
collected using a Hamamatsu Flash 4.0 sCMOS camera. Two-photon imaging was 
performed using a Zeiss 7 MP with GaAsP non-descanned detectors housed at the 
University of Maryland School of Medicine confocal facility. Coherent Chameleon and 
OPO lasers were used for excitation. Fluorescence was filtered using an ET680 short pass 
filter for two-photon microscopy (Chroma) prior to separating polarizations with a 1 inch 
broadband polarizing beamsplitter cube (Thorlabs) mounted using a custom 3D printed 
cube. Images were collected using a 10×, 0.3 NA Plan-apochromat objective lens. In vivo 
imaging was performed on C57Bl/6 mice under isoflurane anesthesia.  
 
Image Analysis 
Image analysis was performed using Fiji (ImageJ) open-source image processing 
software. Polarization images were cropped and aligned using either the Zeiss Axiovision 
software or Fiji’s built-in StackReg registration plugin. In Fiji, regions of interest (ROIs) 
were drawn around each cell, as well as one in the background. ROI intensities were 
background subtracted in each channel to estimate fluorescence emission intensity, and 
anisotropy was calculated as described by Lakowicz et al31.. Anisotropies were calculated 
using the conventional equation30:  
𝑟 =
𝑃 − 𝑔𝑆
𝑃 + 2𝑔𝑆 
 (Where g is the correction factor that accounts for differences in polarization 
transmission efficiencies within the instrument. The g-factor was calculated using an 
isotropic fluorescein solution as described by Piston et al.32 Δanisotropy was calculated 
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by subtracting the anisotropy at each time point by the anisotropy at the time point right 
before drug addition. The magnitude of the anisotropy changes were calculated by taking 
the difference between the average anisotropy when the signal peaked or plateaued and 
the average anisotropy of the baseline time points before drug was added.  
 
Protein Purification  
Purification of the FLARE-Cameleon sensors was done using the BL21-RIL 
Codon Plus strain of E. coli, which were transformed with the construct cloned in the 
pRSET-B vector, with a Poly-His tag in the header sequence to allow for metal ion 
binding. The cells were grown to an OD of 0.2, when expression was induced with IPTG 
and allowed to grow overnight. The cells were then pelleted, frozen, resuspended, and 
lysed by sonication. Protein purification was performed using column chromatography 
with Ni-NTA resin. Fractions were collected and analyzed using SDS-PAGE; fractions 
showing sufficiently pure protein product were pooled. 
 
In vitro Calcium Calibration 
In vitro calibration of the FLARE-Cameleon sensor was performed using 
fluorescence anisotropy spectroscopy in solutions with varying concentrations of free 
calcium in a temperature-controlled environment. These solutions were made by titrating 
known concentrations of free EGTA and calcium-saturated EGTA at pH 7.1 (Calcium 
Concentration Kit #1--Thermo Scientific). The fluorescence anisotropy was measured 
using a Photon Technology International QuantaMaster spectrofluorometer equipped 
with a Xenon flash lamp, fluorescence polarizers, and a Peltier cuvette holder for 
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temperature control. Anisotropies were calculated using integrated intensities of S- and P-
polarized emission spectra. The correction factor G was measured by measuring the P- 
and S-polarized emission spectra of fluorescein, which is assumed to be isotropic, and 
taking the ratio of their measured integrated fluorescence intensities. To determine the 
dissociation constant (Kd) and Hill coefficient (n), the anisotropy vs. calcium 
concentration data were fit to the following equation: 
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Compartmentalized biochemical activities are essential to all cellular processes, 
but there is no generalizable method to visualize dynamic protein activities in living cells 
at a resolution commensurate with their compartmentalization. Here we introduce a new 
class of fluorescent biosensors that detect biochemical activities in living cells at a 
resolution up to three-fold better than the diffraction limit. Utilizing specific, binding-
induced changes in protein fluorescence dynamics, these biosensors translate kinase 
activities or protein-protein interactions into changes in fluorescence fluctuations, which 
are quantifiable through stochastic optical fluctuation imaging. A Protein Kinase A 
(PKA) biosensor allowed us to resolve minute PKA activity microdomains on the plasma 
membrane of living cells and uncover the role of clustered anchoring proteins in 
organizing these activity microdomains. Together, these findings suggest that 
biochemical activities of the cell are spatially organized into an activity architecture, 
whose structural and functional characteristics can be revealed by these new biosensors. 
Introduction 
Protein-based nanomachinery processes biochemical information and underlies all 
aspects of cellular function. Coordinated protein assembly and biochemical activity at 
specific loci in living cells ultimately leads to functional changes in cell growth, division, 
migration, or programmed death. An emerging picture is that these biochemical activities 
are dynamically regulated in various temporal waveforms1,2 and spatially organized into 
distinct micro- or nano-domains3–5. The concept suggests that in addition to their physical 
structure, cells also maintain an “activity architecture” that is composed of organized, 
activated molecules and their regulatory partners. This model has not been directly tested, 
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and critical questions about spatial organization of biochemical activities remain. The 
classical example of compartmentalized signaling is that of PKA, where PKA 
holoenzyme is anchored3 via A Kinase Anchoring Proteins (AKAPs) into signaling 
microdomains. However, this compartmentalization is achieved through the regulatory 
(R) subunits rather than the catalytic (C) subunits. PKA stimulation and subsequent 
release/diffusion of the C subunit would diminish this spatial compartmentalization. 
Therefore, even in this classical model, it is unclear whether and how the kinase activity 
is spatially organized in living cells. In recent years, many superresolution imaging 
methods that reveal the location of nanoscale cellular features6,7 with vastly improved 
spatial resolution, such as STED8, PALM/STORM9, 10, SOFI/pcSOFI11, 12, and SIM13, 
have emerged. While there have been considerable efforts to move superresolution 
imaging beyond biomolecule localization14–16, currently there is no general methodology 
to visualize dynamic biochemical activities such as protein-protein interactions and 
posttranslational modifications in live cells at superresolution. Here, we address this need 
by introducing a new class of generalizable, genetically encodable biosensors that 
enabled the first direct visualization of dynamic biochemical activities at a resolution 
beyond the diffraction limit. Using these new biosensors in combination with existing 
superresolution techniques, we report direct evidence of highly active PKA activity 
microdomains in the plasma membrane. 
Results 
Discovery and Characterization of FLINC 
Examining the fluorescence dynamics of TagRFP-T in a series of plasma 
membrane-tethered constructs, we discovered that the proximity of Dronpa17 significantly 
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increases the fluorescence fluctuations of TagRFP-T18. We characterized this 
phenomenon using Dronpa-TagRFP-T (DpTT), where these two fluorescent proteins 
(FPs) are directly fused together by a short flexible linker. Several characteristics were 
revealed. First, fluctuations are easily detected in live cells expressing membrane targeted 
DpTT (Figure 3.1a, Figure 3.2). The single molecule fluorescence fluctuations generated 
by purified DpTT is quantitatively more robust than that from TagRFP-T (Figure 3.1b). 
Secondly, this effect occurs specifically between tethered Dronpa and TagRFP-T (Figure 
3.1c). Thirdly, the external residues of Dronpa, not its chromophore, are key determinants 
of this effect (Figure 3.1d, Figure 3.2). Lastly, decreasing the distance between Dronpa 
and TagRFP-T by using rigid helical linkers of successively shorter lengths19 revealed a 
corresponding increase in TagRFP-T fluorescence fluctuations (Figure 3.1e), indicating 
an effective range of 5–6 nm. 
We termed this phenomenon Fluorescence fLuctuation INcrease by Contact 
(FLINC). Despite a low intrinsic affinity between Dronpa and TagRFP-T (Figure 3.3, Kd 
= 159–917 µM), the high effective concentrations in the fusions facilitate their 
intramolecular binding. While TagRFT-T, like many FPs, “blinks” stochastically20, 21, the 
specific binding of Dronpa can alter the blinking behavior of TagRFP-T, making a larger 
percentage (25%) of TagRFP-T undergo dark-state conversion at a 25% faster rate 
(Figure 3.4). This photophysical mechanism gives rise to the modulated single molecule 
fluorescence fluctuation that can be utilized to assess whether Dronpa is in close 
proximity to TagRFP-T. 
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Figure 3.1 TagRFP-T (TT) red fluorescence fluctuations increase with 
Dronpa (Dp) proximity in a distance-dependent manner. 
a). Representative images and single-pixel fluorescence intensity traces in 
HeLa cells expressing DpTT (Dronpa–linker–TagRFP-T), n = 7 cells) and 
TagRFP-T alone (n = 8), excited by a 561-nm laser. A.u., arbitrary units. 
Scale bar, 10 µm. b). Aggregated mean normalized autocorrelation 
function (ACF) of many single-molecule fluorescence traces from purified 
fluorescent DpTT and TagRFP-T. The amplitude increase demonstrates 
the clear gain in autocorrelation signal from increased millisecond 
fluctuations of DpTT. c). Quantified fluctuation in various constructs, 
demonstrating the specific nature of the fluctuation increase. TT (n = 8), 
DpTT (n = 7), Dp + TT (n = 9), EGTT (EGFP–linker–TagRFP-T, n = 8) 
and EGFP–linker–mCherry (EGmCh, n = 9) were analyzed. d). Quantified 
fluctuation in various mutant constructs, demonstrating that Dronpa's 
chromophore is not involved, but external Dronpa residues are important 
for the phenomenon. TT alone (n = 8), WT (n = 7); chromophore mutants 
(mut) DpS142D–TT (S142D, n = 8) and DpC62G Y63G–TT (GGG, n = 
11); and FP surface mutants DpN102I–TT (N102I, n = 12) and DpN102I 
R149E–TT (NIRE, n = 9) were analyzed. e). A variable number of rigid 
helical repeats permit measurement of distance dependence and sensitivity 
of changes in fluctuation. Hn, number of rigid (EAAAK) repeats; DpTT 
(short linker) and Dp + TT (not fused) were included as comparisons. H2–
H5 linkers are shown with the nominal FP distances reported in the  
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Figure 3.1 (continued) literature. All constructs in e were targeted to the 
plasma membranes of HeLa cells by the lyn sequence and examined for 
the following: DpTT (n = 5), H1 (n = 7), H2 (n = 6), H3 (n = 14), H4 (n = 
17), H5 (n = 10) and Dp + TT (n = 9). Pairwise t-test results in c–e are 
shown for data compared with the reference (ref) construct. NA, not 
applicable; NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001. In all 
dot plots and e, center line and whiskers mark the average and s.e.m., 







Figure 3.2 Additional Characterization in the Discovery of FLINC 
a). Representative images from a single, 35 ms exposure using 561 nm 
laser on HeLa cells expressing DpTT and control constructs: TagRFP-T 
alone (TT), co-targeted Dronpa and TagRFP-T (Dp+TT), Dronpa-linker-
TagRFP-T (DpTT), EGFP-linker-TagRFP-T (EGTT). Scale bar: 10 µm. b). 
Averaged fluorescence intensity of HeLa cells expressing various 
constructs. n numbers are: TT (8), DpTT (7), Dp+TT (9), EGTT (8), and 
EGFP-linker-mCherry (EGmCh, n=9). c). Representative images from a 
single, 35 ms exposure using 561 nm laser on HeLa cells expressing 
mutant DpTT constructs: Dp[S142D]-TT (S142D), Dp[C62G/Y63G]-TT 
(GGG), Dp[N102I]-TT (N102I), Dp[N102I/R149E]-TT (NIRE). Scale 
bar: 10 µm. d). Averaged fluorescence intensity of HeLa cells expressing 
various mutant and control constructs; tandem model DpTT containing 
wild-type Dronpa (WT), singly-expressed TagRFP-T (TT-alone).  n 
numbers are: TT-alone (8), WT (7), S142D (8), GGG (11), N102I (12), 
and NIRE (9). e). Normalized skewness quantification demonstrates that 
Dronpa fluctuation is not significantly affected by co-transfection 
(Dp+TT) or fusion (DpTT) with TagRFP-T on the membrane of HeLa 
cells. f). Normalized average fluorescence intensity of bacterial colonies in 
error-prone (K178R, N208K) and site-directed (residues N102 and R149) 
mutagenesis. Pair-wise t-test results in (B), (D), (E) are marked where data 
were compared with the construct marked “ref”; n numbers are marked in 
the corresponding columns. n.s.: not-significant; *: p<0.05; **:  
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Figure 3.2 (continued) p<0.01; ***: p<0.001 where applicable. Center 
line and whiskers mark mean and s.e.m. values, respectively. N numbers 






Figure 3.3 In Vitro Characterization of FLINC  
a). Size-exclusion chromatography permits a qualitative assessment of the 
interaction between Dronpa and TagRFP-T. Sizes of the protein oligomers 
are as indicated. A peak at 92 kDa was observed only in the mixed 
solution, indicating a trace amount of a 3-fluorescent-protein hetero-
oligomer formed at protein concentrations of 60 µM each. Color codes: 
red, TagRFP-T; green, Dronpa; orange, algebraic sum of Dronpa/TagRFP-
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Figure 3.3 (continued) T chromatographs; blue, mixture. b). SedAnal plot 
of ΔC as a function of cell radius for fitting of Dronpa+TagRFP-T mixed 
sample data from analytical ultracentrifugation. The experimental data are 
shown as black dots, while the calculated fitting curve for the A + B ↔ C 
model is shown as a solid blue line. Data from scans 55 to 100 are 
included in this fit; the input parameters include: S(Dronpa) = 2.15, 
S(TagRFP-T) = 3.30, and S(Dronpa+TagRFP-T) = 4.0. c). Absorption and 
d). fluorescence spectroscopy of purified DpTT fractions compared to 
TagRFP-T or Dronpa. e). Electrostatic surfaces of Dronpa and TagRFP-T 
calculated by the Adaptive Poisson-Boltzmann Solver (APBS) plug-in in 
PyMOL. The basic pocket in Dronpa and the acidic patch around the 
chromophore in TagRFP-T, both features believed to be important for 




Figure 3.4 The photophysical characteristics differences between 
DpTT and TT (TagRFP-T) is mainly observed in dark-state 
conversion 
a). A simplified schematic depicting the 4-state model of the TagRFP-T 
chromophore transition. b). Results of the Dark-State Conversion (DSC) 
measurement and fit. The bottom two figures summarize the difference in 
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Figure 3.4 (continued) DSC time constant and Percent DSC. c). Results 
of the Ground-State Recovery (GSR) measurement and fit. d). Results of 
the fluorescence (em) life time measurement; IRF is instrument response 
function. Pair-wise t-test results in (b) are marked where data were 
compared with the construct marked “ref”; n numbers are marked in the 
corresponding columns. *: p<0.05. Center line and whiskers mark mean 




FLINC therefore forms the basis of a new class of fluorescent biosensors that 
could provide activity information in superresolution. Engineered molecular switches can 
modulate the proximity between Dronpa and TagRFP-T in a manner similar to FRET-
based biosensors22. The output of these FLINC-based biosensors is activity-dependent 
changes in the fluorescence fluctuations, which are readily quantified at superresolution 
using photochromic Stochastic Optical Fluctuation Imaging (pcSOFI)11. In pcSOFI, time 
series of fluorescence images are recorded to obtain many single molecule fluctuations 
across the field of view. Pair-wise cross-cumulant, calculated utilizing the appropriate 
pixel-pairings, yields an autocorrelation-like “pcSOFI value” at sub-pixel resolution that 
quantifies the strength of fluctuation23 with high signal-to-noise (Figure 3.5). The 
collection of pcSOFI values constitutes a quantitative image, which provides a 





Figure 3.5 Signal-to-noise estimation for pcSOFI imaging 
Jackknife resampling on a typical FLINC dataset demonstrates the 
accuracy of pcSOFI imaging in terms of signal-to-noise ratio (SNR). We 
obtain a high SNR of 6.7. 
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We modeled FLINC-based activity biosensors after FRET-based biosensors, 
which serve as surrogate substrates of the kinase of interest. Phosphorylation of these 
biosensors leads to a change of fluorescence properties, thereby allowing us to monitor 
kinase activity by imaging a reporter, without labeling or disrupting the active kinase. In 
the FLINC-based PKA biosensor, we combined the molecular switch in AKAR24 with an 
EV linker (AKARev)25 with Dronpa and TagRFP-T into FLINC-AKAR1 (targeted to the 
plasma membrane). Here, FLINC would be affected in a phosphorylation-dependent 
manner, such that high pcSOFI values indicate high PKA activities (Figure 3.6a). 
Normalizing the pcSOFI values to correct for uneven biosensor distribution (Figure 3.7), 
we could quantify PKA activity both at the single pixel level or averaged across the entire  
cell. The average normalized pcSOFI value rapidly increased in the first minute after 
PKA activation in HeLa cells treated with a cocktail of the adenylyl cyclase activator 
forskolin (Fsk) and phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX), 
reaching a plateau at 25–39% increase after 7–10 minutes (Figure 3.6b-d) and showing a 
dynamic range of up to 40% increase. Addition of the PKA-specific inhibitor H-89 (20 
µM) gradually decreased the average normalized pcSOFI value, demonstrating the 
reversibility. Additional experiments using a negative control biosensor that cannot be 
phosphorylated (Figure 3.6c-d) and membrane-targeted PKA inhibitor PKI (Figure 3.6c) 
demonstrated that the response was dependent on phosphorylation of the biosensor and 
PKA activity, respectively. Time courses with H-89 inhibition and submaximal dosage of 
Fsk (Figure 3.8) showed that FLINC-AKAR1 could accurately report over a range of 
PKA activity. We could quantify PKA activity initially every 5 minutes (Figure 3.6c), 
and with further development every 30 s (Figure 3.6d). The kinetics of PKA stimulation 
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as monitored by FRET-based or FLINC-based AKAR showed no significant difference 
(FRET t1/2 = 1.2 min, n = 7; FLINC t1/2 = 0.73 min, n = 4). Importantly, our analysis of 
FLINC-AKAR1 fluctuations generated superresolution images of PKA activity at each 
time point throughout the treatment course. Monitoring the same profile line in the 
normalized pcSOFI images before and after Fsk/IBMX treatment (Figure 3.6e) showed 
that we can resolve sub-diffraction-limit activity features (Figure 3.6f) that have 
responded to stimulation. Actin-targeted FLINC-AKAR1 enabled us to distinguish the 
stimulated PKA activity with an average Gaussian full-width-half-maximum of 179 ± 6 
nm (n = 7) and 116 ± 6 nm (n = 7), consistent with the respective use of second- and 
third-order analyses (Figure 3.9a-b). Furthermore, we could resolve the stimulated 
membrane PKA activity in converging filopodial features separated by 160 nm and 107 
nm using second- and third-order cumulant analyses, respectively (Figure 3.9c-d). Under 
the conditions described here, biosensor diffusion does not affect the temporal and spatial 
resolution of pcSOFI11 and its accurate quantification of FLINC. Thus, as a reporter of 
kinase activity, FLINC-AKAR1 provides not only a consistent readout for PKA activity, 
but also allows us to monitor the dynamic changes of PKA activity with high contrast at 
superresolution. 
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Figure 3.6 FLINC resolves PKA activity microdomains on the plasma 
membrane at super-resolution. 
a). Schematic of the FLINC–AKAR design principle, the domain structure 
of FLINC–AKAR1 and the acquisition of super-resolution activity images 
with pcSOFI. b). FLINC–AKAR1 super-resolution images clearly resolve 
the response to Fsk/IBMX stimulation (Fsk 50 µM and IBMX 100 µM) 
and inhibition (H-89 20 µM), and detailed spatial information on 
membrane PKA activity emerges. Color scales are identical. c). Mean 
normalized pcSOFI response time course from live HeLa cells expressing 
WT (n = 9 cells) FLINC–AKAR1, nonphosphorylatable mutant (TA, n = 
7) and WT coexpressed with PKI (WT + PKI, n = 4), after PKA 
stimulation and inhibition. d). The normalized pcSOFI response time 
course from live HeLa cells expressing WT (n = 4) FLINC–AKAR1 and 
nonphosphorylatable mutant (TA, n = 5), after PKA stimulation and 
inhibition, determined with a fast acquisition imaging scheme. e). A 
profile line at the same position across the pcSOFI images before and after 
Fsk/IBMX (FI) stimulation clearly demonstrates sensing of PKA activity 
at super-resolution; the profile is marked by a red line in b. f). Zoom view 
of the active PKA feature (p1) in f, showing resolution of the Gaussian 
fitting and full width at half maximum (FWHM) size of this 
subdiffraction-limit PKA activity microdomain. g). Comparison of the 
changes in the fraction of membrane area occupied by punctate structures 
after stimulation across various FLINC constructs, all targeted with the  
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Figure 3.6 (continued) same CAAX motif. In FLINC–AKAR1 
experiments, cells (WT, n = 10; TA, n = 8) were stimulated with 
Fsk/IBMX; in DpTT experiments, cells (n = 8) received no drug treatment. 
Unless indicated otherwise, pairwise t-test results are shown for data 
compared with the reference (ref) construct. NS, not significant; **P < 








Figure 3.7 Validation for pcSOFI Normalization Algorithm 
a). and c). show average fluorescence images of plasma membrane 
targeted FLINC-AKAR1, where uneven distribution of the probe could be 
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Figure 3.7 (continued) observed. b). and d). show normalized pcSOFI 
images of the same cells. e). The effectiveness of the pcSOFI 
normalization scheme is demonstrated by performing normalization on 
HeLa cells expressing membrane targeted Dronpa. Normalization removes 
the clearly present concentration bias, as seen by the profile (averaged 









Figure 3.8 Additional control data supporting the accuracy, biological 
relevance and function of FLINC biosensing 
a). Treatment of Fsk/IBMX stimulated HeLa cells with 20 µM H89 over 
time can inhibit PKA activity to baseline levels. b). FLINC-AKAR1 is 
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Figure 3.8 (continued) sensitive to intermediate levels of PKA activity as 
demonstrated by representative response during 1) H89 inhibition (left 
column of b), and 2) submaximal forskolin (Fsk) dosage (right column of 
b). The response of the FRET-based biosensor is provided for comparison 
in each case. In (a), center line and whiskers mark mean and s.e.m. values, 
respectively. 
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Figure 3.9 Resolution analyses of FLINC-KAR biosensors 
In each row, the feature can be located in the mean fluorescence (Avg) images, 
and the enzyme activity detected from the feature is shown in the pcSOFI images, 
labeled by order of calculation. a-b). Resolution analyses on lifeact-targeted 
FLINC-AKAR1, where the PKA activity detected on actin filament under 
different treatments is quantified by either 2nd or 3rd order pcSOFI. The profile 
of the filament at the red line was plotted in the graph to the right. The activity 
profile before and after Fsk/IBMX stimulation of PKA are shown to highlight the 
sensing of activity during superresolution imaging. After Gaussian fitting of many 
filament profile lines, the average FWHM the filaments were found to be 179±6 
nm (n=7) and 116±6 nm (n=7) for (a) 2nd and (b) 3rd order pcSOFI images, 
respectively. (c-e) Resolution analyses using filopodia features. In each panel, the 
mean fluorescence (Avg) and the pcSOFI (2nd or 3rd order) image of the same 
region of interest are shown, while the profiles of the active feature marked by the 
red dashed line were plotted in the graph to the right. As demonstrated by a graph 
and a surface plot to aid the eye at the right end of rows c-e, the joints of two 
filopodial features can be clearly resolved across 3 pixels, allowing the spatial 
resolution to be estimated. We find a resolution of 160 nm for the 2nd order 
pcSOFI with FLINC-AKAR1 (c), a resolution of 107 nm for the 3rd order 
pcSOFI with FLINC-AKAR1 (d), and a resolution of 160 nm for 2nd order 






PKA Activity Microdomains 
 The PKA activity maps generated by FLINC-AKAR1 revealed many minute and 
highly active punctate features on the basal membrane of living cells. These activity 
puncta, with a mean diameter of 350 nm, were clearly resolved after Fsk/IBMX 
stimulation. Activating PKA induces a 2-fold increase in microdomain coverage over the 
basal membrane, and is not observed with the DpTT control or the non-phosphorylatable 
mutant (TA) (Figure 3.6g). Using Stochastic Optical Reconstruction Microscopy 
(STORM) in total internal reflection fluorescence (TIRF) condition, we further verified 
the presence of these highly active PKA microdomains. Phospho-PKA-substrates (p-
PKAsub) were clearly clustered (Figure 3.10a-b), forming distinct microdomains on the 
basal membrane with a mean diameter of approximately 250 nm (Figure 3.10c). The 
basal membrane of cells stimulated by Fsk/IBMX again displayed a significant 4.8 fold 
increase in phospho-PKA-substrate clusters per unit membrane area (Figure 3.10d). All 
these characteristics observed in STORM are consistent with those observed using 
FLINC-AKAR1 in live cells. Thus, despite the conventionally held views of rapid cAMP 
diffusion26–30 and mobility of PKA catalytic subunits31,32, PKA activity is not uniform but 




Figure 3.10 STORM superresolution imaging of PKA activity 
microdomains using a phospho-PKA substrate antibody 
a). A representative view of the p-PKAsub localization on the basal 
membrane of HeLa cells. Inset: a zoom-view illustrating the PKA 
microdomains observed. b). Ripley’s K analysis of p-PKAsub 
localizations show clear clustering above random sampling. The average 
clustering length scale is 102 nm (n = 3). c). and d). Mean-shift clustering 
analysis reveals the average cluster diameter and number of clusters on the 
basal membrane, respectively, upon Fsk/IBMX stimulation (n=3 cells), 
H89 inhibition (n=4 cells), and without pretreatment (n=3 cells). Unless 
indicated otherwise, pair-wise t-test results are marked where data were 
compared with the construct marked “ref”. n.s.: not-significant; *: p<0.05; 
**: p<0.01; ***: p<0.001 where applicable. In c) and d), center line and 
whiskers mark mean and s.e.m. values, respectively. 
 113 
Clustered anchoring proteins spatially organize PKA activity microdomains 
AKAPs are critical components of the PKA compartmentalization. We set out to 
directly determine the precise spatial relationship between highly active PKA 
microdomains and the loci of specific PKA anchoring. AKAP79/AKAP5 is a doubly-
lipidated, predominately membrane-localized scaffold known to associate with RII PKA 
holoenzymes and other regulators of PKA signaling33,34. Two-color STORM imaging in 
fixed cells (Figure 3.11a-b) showed that AKAP79 was itself highly clustered (Figure 
3.11c, Figure 3.12a-b), with a mean diameter of 127 nm. Getis-Franklin co-clustering 
(Figure 3.11d) demonstrated a high degree of spatial correlation between AKAP79 and p-
PKAsub (Figure 3.12c). 76% of total AKAP79 localizations, whether in clusters or 
dispersed, were associated with p-PKAsub microdomains. Surprisingly, however, a total 
of 24% of AKAP79 localizations could not be associated with p-PKAsub, suggesting 
heterogeneity of AKAP-mediated complexes and that a sub-pool of these complexes 
could be regulated differentially, e.g. due to a difference in phosphatase activity. Through 
a combination of AKAP79 localization and FLINC-AKAR1 imaging in the same cells, 
we observed characteristics that mirrored those reported above. Significant overlap with 
PKA activity microdomains was observed above random clustering (Figure 3.11c), and 
we again observed so-called “orphaned” AKAP79 molecules. 
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Figure 3.11 Representative data analysis for STORM imaging and 
STORM/FLINC imaging 
a). and b). Double exponential fit and parameters for the spot-linking or 
blinking-rejection utilized in post-processing of STORM dataset in 
Alexa568 and Alexa647 dyes, respectively. All data were treated by spot-
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Figure 3.11 (continued) linking prior to further analysis to avoid over-
counting. c). Representative processing from mean-shift clustering 
analysis. c1). Identification and clustering of phospho-PKA substrates 
localizations; c2). Identification and clustering of AKAP79 localizations; 
c3). Convex-hull cluster pairs highlighting the AKAP79 clusters (blue) 
and their respective phospho-PKA substrate clusters (red). c4). Histogram 
displaying the frequency of occurrence for centroid distances between 
AKAP79 clusters and their respective nearest p-PKAsub clusters; 
representative of n=5 cells. c5). Histogram displaying the frequency of 
occurrence for centroid distances between AKAP79 and FLINC 
microdomain; representative of n=5 cells. d). Representative processing 
from the Getis-Franklin co-clustering analysis. d1). Self-clustering of 
AKAP79 by Getis-Franklin, which is a precursor to co-clustering analysis; 
red color indicates increasing tendency of clustering. d2). Co-clustering 
analysis plotl; red color indicates increasing tendency of clustering. d3). 
Representative quadrant analysis from Getis-Franklin co-clustering, 





Figure 3.12 A kinase–anchoring proteins (AKAPs) are coclustered 
with PKA activity microdomains and are required for microdomain 
formation 
a). A representative two-color STORM image of p-PKAsub (magenta) and 
AKAP79 (green), with specific examples of the p-PKAsub/AKAP79 
relationship shown beneath. b). (n = 5 cells) Ripley's K analysis of 
AKAP79 localizations shows clear clustering above random sampling. c). 
Getis–Franklin coclustering analyses of the two-color STORM images, 
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Figure 3.12 (continued) identifying populations with different p-
PKAsub/AKAP79 relationships; the majority (55 + 21 = 76%) of 
AKAP79 is associated with p-PKAsub (n = 5). d). Representative live-cell 
super-resolution FLINC–AKAR1 images of stimulated PKA activity after 
the disruption of AKAP–PKA RII interactions with a synthetic AKAP 
disruptor, STAD-2 (n = 10), in comparison with its scrambled control (n = 
6). Scale bar, 10 µm. The color scales are identical. e). The effect of RII–
AKAP disruption on PKA activity microdomains, quantified by fold 
change in microdomain coverage. Cells were pretreated with either 
STAD-2 (n = 10) or scrambled peptide control (n = 6) before Fsk/IBMX 
stimulation. Unless indicated otherwise, pairwise t-test results are shown 
for data compared with the reference (ref) construct. *P < 0.05. In c and e, 
center line and whiskers mark the average and s.e.m., respectively. 
  
 118 
Next we tested whether, beyond a high degree of spatial correlation, AKAP 
anchoring is required for the formation of highly active membrane PKA microdomains in 
living HeLa cells. To this end, we used the synthetic peptide (STAD-2), which 
specifically disrupts the interaction between AKAPs and the PKA regulatory subunit RII 
isoform35. Consistent with previous observations, the membrane PKA activity in living 
cells pretreated with STAD-2 was low after Fsk/IBMX stimulation (Figure 3.13) and 
devoid of highly active PKA microdomains, in contrast to cells treated with scrambled 
peptide (Figure 3.12d,e). These live cell data indicated that beyond a high degree of 






Figure 3.13 Normalized pcSOFI response to inhibition by STAD-2 
and its scrambled peptide control 
STAD-2 treatment (n=6) to dissociate PKA-RII subunit from A Kinase 
Anchoring Proteins (AKAP) inhibited membrane PKA activity while 
scrambled-control peptide (n=3) did not. 
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Polarized Distribution of Activity Microdomains 
Having confirmed that cells do maintain a well-structured PKA spatial signaling 
architecture, we next examined the presence and organization of highly active PKA 
microdomains during integrin-dependent cell migration, which requires effective 
polarization. Chinese Hamster Ovary cells stably expressing α4 integrin (α4CHO) exhibit 
a gradient of PKA activity as they migrate toward wounds36. This migration-dependent 
PKA gradient was resolved at superresolution using live α4CHO cells expressing FLINC-
AKAR1 (Figure 3.14a). The difference between the normalized pcSOFI values in the 
leading and that in trailing regions was highly significant (WT, Figure 3.14b) and absent 
in cells expressing the non-phosphorylatable biosensor (TA, Figure 3.14c). Inhibiting 
PKA activity globally using H-89 markedly suppressed PKA activity in the leading front, 
whereas the trailing edge showed little change (Figure 3.15). The gradient observed using 
FLINC was approximately linear (Figure 3.14d), similar to that seen using a FRET-based 
biosensor36. However, the superresolution images reveal that the leading front of the cell 
hosted many microdomains of high PKA activity, which were missing in the trailing end. 
With a median diameter of approximately 280 nm, these highly active microdomains in 
CHO cells displayed significantly different levels of PKA activity depending on their 
subcellular location, with most elevated activity at the filopodia. In 8/9 cells, 
microdomains within the filopodia displayed a significantly higher PKA activity as 
compared to those on the remainder of the basal membrane (Figure 3.14e), consistent 
with the model that a pool of PKA molecules (such as integrin-anchored Type I PKA) are 
highly active at the very tip of migrating cells37. These data suggest that distinct PKA 
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microdomains in the same cell can have differentially regulated amplitude and 
spatiotemporal characteristics. 
 
FLINC is a General Platform for Biosensing 
To demonstrate the generalizability of the design, we constructed a FLINC 
biosensor for Extracellular signal-Regulated Kinase (ERK) activity based on EKARev25 
(Figure 3.15a). In HEK293 cells expressing plasma membrane-targeted FLINC-EKAR1, 
pcSOFI values again provided consistent and robust ERK activity readouts. Stimulation 
of ERK using epidermal growth factor (EGF, 100 ng/mL) increased the averaged 
normalized pcSOFI value by 21–27% within 10 minutes (WT, Figure 3.16b n = 16). 
Stimulation in cells expressing a non-phosphorylatable mutant biosensor or pretreated 
with an upstream inhibitor of ERK (U0126, 20 µM) gave no response (TA/pretreat, 
Figure 3.16b). The superresolution ERK activity maps (Figure 3.16c) showed a similar 







Figure 3.14 PKA activity gradient of a migrating cell at super-
resolution. 
a). The PKA activity gradient in a migrating α4CHO cell expressing WT 
FLINC–AKAR1. Scale bar, 10 µm. b). Average normalized (norm) 
pcSOFI values within leading- and trailing-edge regions of migrating cells 
show clearly different PKA activities. c). Migrating α4CHO cells 
expressing WT FLINC–AKAR1, compared with cells expressing a 
nonphosphorylatable TA mutant, show a significant gradient in terms of 
normalized pcSOFI values. Pairwise t-test results are shown. d). 
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Figure 3.14 (continued) Representative PKA activity profile (n = 9 cells) 
observed along the migration direction, for FLINC–AKAR1 and its TA 
mutant. e). Representative data (n = 9) showing that active microdomains 
within the filopodia have significantly higher PKA activity than that 
elsewhere on the basal membrane of migrating CHO cells; basal-
membrane regions are indicated according to their increasing distance 
from the leading edge of the migration direction (filopodia, leading edge, 
front and middle) (n = 9). Unless indicated otherwise, pairwise t-test 
results are shown for data compared with the reference (ref) construct. NS, 
not significant; ***P < 0.001. In c and e, center line and whiskers mark 





Figure 3.15 Inhibition of global PKA activity using H-89 reduces PKA 
activity at the leading front 
Normalized pcSOFI images and their corresponding histograms for a 
migrating α4 CHO cell at t=0 min, 5.5 min, and 22 min after addition of 
20 µM of H-89, a PKA inhibitor. All images are displayed using the same 
color scale. A shift to lower normalized pcSOFI values was observed for 





Figure 3.16 FLINC-based design is generalizable. 
a). Domain structure of FLINC–EKAR1. b). Normalized pcSOFI response 
time course from live HEK293 cells expressing WT FLINC–EKAR1 (n = 
16 cells), nonphosphorylatable mutant (TA, n = 18) FLINC–EKAR1 and 
cells expressing WT but pretreated with the ERK upstream inhibitor 
U0126 (20 µM; inhibitor pretreat, n = 7), all subjected to growth-factor 
stimulation (EGF 100 µM). c). Representative super-resolution images (n 
= 16) of ERK activity dynamics after growth-factor stimulation and 
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Figure 3.15 (continued) chemical inhibition. Scale bar, 10 µm. d,e). 
Schematic of the design (d) and normalized pcSOFI time course of the 
bimolecular PPI sensor based on FKBP–rapamycin–FRB (n = 12) in 
response to rapamycin (100 nM) (e). f). Normalized pcSOFI images of a 
HeLa cell before and after stimulation with rapamycin to induce the 
dimerization between FKBP and FRB. Scale bar, 10 µm. The color scales 





FLINC could also be harnessed to monitor protein-protein interactions (PPI), and 
we demonstrate this by using the inducible dimerization system of cytosolic FK506 
Binding Protein (FKBP) and membrane targeted FKBP12-Rapamycin Binding domain 
(FRB, Figure 3.15)38. Addition of rapamycin (100 nM) led to the rapid 
heterodimerization of FKBP and FRB, which could be detected by a fast normalized 
pcSOFI value increase across the cell membrane that plateaued at 15% in 20 minutes 
(Figure 3.16e,f). When optimized, FLINC can also detect weaker PPI. We split FLINC-
AKAR1 into two separate constructs consisting of a diffusible FHA1-Dronpa and a 
membrane-targeted PKA-substrate-TagRFP-T. PKA phosphorylation of the substrate 
recruits cytosolic FHA1 and induce a corresponding normalized pcSOFI signal increase, 
even though the affinity between FHA1 and phospho-substrate is ~ 0.5 µM39 (Figure 
3.17). These examples showcase the generalizability of FLINC-based biosensors and its 




Figure 3.17 Detection of the weak protein-protein interaction between 
FHA1 and phospho-PKA substrate 
a). Schematic of the bi-molecular version of FLINC-AKAR1. It responses 
to PKA stimulation at the membrane by detecting the binding of phospho-
substrate and FHA1, a weak protein-protein interaction (kD ~ 0.5 µM). b). 
11 min after Fsk/IBMX stimulation the wild-type (WT, n=3) biosensor 
shows significant response compare to the non-phosphorylatable mutant 
(TA, n=4). Pair-wise t-test result *: p<0.05; center line and whiskers mark 











The nanometer sensitivity of FLINC enabled us to emulate the powerful 
molecular ruler FRET40, 41 and develop new biosensors for kinase activities and PPI. 
Although the spatial resolution is not as high as BiFC-based superresolution methods14–16, 
the fact that FLINC does not require complementation and fluorophore maturation allows 
us to achieve reversibility and fast response in the biosensors for investigating dynamic 
signaling activities in live cells. FLINC-based biosensors may be created and optimized 
in a fashion similar to their FRET-based counterparts. We note that a FLINC biosensor 
utilizing the original, compact molecular switch in AKAR224 did not give a significant 
signal upon PKA activation, demonstrating that the linker in AKARev is necessary to 
maximize the dynamic range of a FLINC biosensor. In addition to intermolecular 
distance, the FP orientation within a biosensor will be a crucial consideration in future 
designs. Although FLINC is currently limited to Dronpa and TagRFP-T, future studies 
will test other fluorescent proteins mutants for their applicability. As in FRET-based 
biosensor, monomerized fluorescent proteins are preferable, although in our case we have 




While we have demonstrated a relationship between pcSOFI value and FP 
proximity, at this time, pcSOFI value cannot be used to directly infer molecular distance. 
The absolute pcSOFI values depend on biosensor expression and the optical setup 
(especially camera gain and excitation intensity). However, our normalization scheme 
largely removes the expression dependence. Therefore, normalized pcSOFI values can be 
compared across experiments so long as the imaging parameters remain identical. The 
current temporal resolution may fall short for tracking rapid changes. However, we note 
that pcSOFI calculations can converge to a high signal-to-noise43 very quickly. 
Specifically, we utilize only 4 s within a 30 s interval to collect data. The temporal 
resolution will thus improve as more sensitive and faster camera becomes available. In 
principle, as long as fluctuations can be observed, many types of illumination can be used 
to monitor FLINC, including epi-fluorescence and z-sectioning methods such as lattice 
light-sheet. 
Under the conditions described here and previously11, diffusion does not affect the 
accuracy and temporal/spatial resolution of pcSOFI and its quantification of FLINC. This 
is because fluorophore diffusion over the total duration of pcSOFI measurement does not 
lead to distortions as long as the fluorophore motion within a single exposure (35 ms) is 
sufficiently small. Over the imaging time, we can in fact sample the local environment 
more thoroughly by virtue of biosensor diffusion. In our experiments, we estimated that 
biosensor diffusion is within a single pixel during a single exposure; simulations using 
published diffusion coefficients did not reveal distortions. However, depending on the 
local access and sensitivity to phosphatases that resets kinase biosensors, biosensor 
diffusion could potentially lower the spatial resolution of the kinase activity map. In this 
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case, while the PKA activity microdomains resolved will still accurately reflect the 
environment experienced by any endogenous substrate, there would be a slight 
overestimate of the size of PKA activation zone. There is no evidence that the above 
issue was significant in our experiments, however, since the sizes of microdomains 
measured by the both superresolution methods STORM and FLINC were in good 
agreement. 
To our knowledge, this study represents the first demonstration of superresolution 
imaging of dynamic enzymatic activities such as protein kinase activities in living cells. 
PKA substrates are known to be more rapidly phosphorylated when localized to AKAP 
complexes44, consistent with high PKA activity in the vicinity of AKAP-assembled 
signalosomes. We can now visualize the activity zone of these nanomachines, which are 
shown to be larger than the intrinsic flexibility of the PKA holoenzyme complex45. The 
significant self-clustering in AKAP79 and co-clustering of AKAP79 and phospho-PKA 
substrate signals suggest that the clustering of AKAP complexes, and hence an increased 
effective concentration of PKA regulatory subunits, may serve as an efficient means to 
re-capture dissociated C subunit and maintain PKA activity compartmentalization. 
Interestingly, 24% of total AKAP79 were orphaned and not clustered with phospho-PKA 
substrate. This and other data suggest that AKAPs may maintain microdomains with 
varying PKA activity levels, evolving dynamically based on the associated regulatory 
partners such as adenylyl cyclases, phosphodiesterases, kinases, and phosphatases46. As 
PKA represents a classical example of compartmentalized signaling, other biochemical 
activities may be under similarly precise spatiotemporal regulation. These spatial details 




Plasmid and construct generation 
All mammalian constructs were cloned using the pcDNA3.0 vector with a 
modified multiple cloning site. All E. coli constructs were cloned using the pRSET-B 
vector. Plasmids were generated through typical molecular cloning methods using a 
combination of polymerase chain reaction (PCR) and restriction enzyme cloning. PCR 
was always performed using the Phusion polymerase (New England BioLabs) unless 
noted. Cloning and subcloning were performed using E. coli DH5α strain. 
 
Mutagenesis (error-prone PCR and site-directed) 
All site-directed mutagenesis experiments were performed following a published 
protocol47 using the E. coli JM109 strain. The randomized screens at N102 of Dronpa and 
D159 of TagRFP-T were both performed on a wild-type tandem DpTT template using 
fully degenerate primers (NNN). Error-prone PCR was performed using Taq polymerase 
and an in-house dNTP mixture. Eight rounds of consecutive PCR were performed (on 
Dronpa only) using a reverse primer containing the 8-amino acid linker at the 3’ end. 
This ensured that the linker was not subject to mutation. The mutation rate was 
approximated through sequencing, and the 3rd-to-5th-round PCR products 
(approximately < 2% point mutation rate) were selected for further cloning. These mutant 
Dronpa fragments were ligated to a linearized pRSET-B plasmid containing wild-type 
TagRFP-T using the sites BamHI/KpnI. All of the ligate was transformed into JM109 
cells and plated onto LB-Amp agar. The candidate mutants were then screened on the 
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basis of colony fluorescence. Once a candidate was chosen, its fluorescence intensity was 
confirmed by averaging the fluorescence of many colonies over a larger area on the LB-
Amp agar plate. 
 
Mutant screening 
Expression of TagRFP-T causes an intense salmon/pink color due to the 
chromophore absorption. The tandem DpTT construct showed a faint but visible color. 
During error-prone or site-directed mutagenesis screening, we rejected any mutant that 
did not display this color, thereby excluding badly folded mutants and those containing 
premature stop codons and frame shifts. To quantify the effects of the mutations on 
mutant DpTT constructs, E. coli (JM109) expressing the mutants were streaked onto LB-
Amp agar plates. The mean intensity of each mutant in the GFP or RFP channel was 
measured using the same exposure settings on an in-house fluorescence imager, 
illuminated by a broad-spectrum lamp source (MAX-303, Asahi Spectra) and monitored 
by a Thorlabs USB digital camera mounted behind a Thorlabs emission filter wheel 
(maxima/bandwidth in nm; CFP: 430/40; GFP: 535/40; RFP: 630/75). For comparison, 
each plate was streaked with DpTT as well as TagRFP-T colonies as normalizing 
controls. The images were analyzed using ImageJ (v. 1.47g). The site-directed, 
randomized screen at N102 of Dronpa was carried out following the same criteria 




Cell culture, transfection, and pretreatment 
The HeLa and HEK293 cells utilized for these experiments were between 
passages 20–65. Cells were maintained in DMEM growth media supplemented with 10% 
FBS and 1% penicillin/streptomycin. CHO cells (passage 8–22) stably expressing α4 
integrin were maintained in DMEM F12 medium with 10% FBS and 1% 
penicillin/streptomycin. All cells were transfected at an approximate confluency of 70% 
using Lipofectamine 2000 and incubated for 24 hours before imaging. All cells were 
imaged in HBSS buffer at room temperature. To achieve AKAP-PKA RII disruption, 
HeLa cells were incubated with 5 µM of the synthetic disruptor peptide STAD-2 (or its 
scrambled control) in DMEM growth media for 6 hours at 37°C and 5% CO2. 
Immediately prior to imaging, the HBSS imaging buffer was supplemented with the 
appropriate peptide at 5 µM. For migration studies, CHO cells were plated on cover slips 
coated overnight with 10 µg/mL human fibronectin (in DPBS). Cells were grown to a 
monolayer and wounded using a 200-µL pipette tip, then washed and incubated in HBSS 
buffer for 1 hour prior to imaging to induce migration. 
 
Epifluorescence imaging 
All epifluorescence imaging was performed on a Zeiss Axiovert 200M 
Microscope equipped with a xenon lamp and a cooled CCD, under a 40X oil immersion 
objective. FRET microscopy of GFP/RFP biosensors such as FLINC-AKAR1 was 
performed using the following excitation/emission filter combinations 
(maxima/bandwidths in nm): GFP – EX480/30, EM535/45; RFP – EX568/55, 
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EM653/95; FRET: EX480/30, EM653/95. All epifluorescence experiments were 
subsequently analyzed using the MetaFluor software. 
 
Total Internal Reflection Fluorescence (TIRF) imaging 
All pcSOFI TIRF imaging was performed on either a Nikon Eclipse Ti 
microscope equipped with a Photometric Evolve 512 EMCCD, a Melles Griot argon laser 
(GFP excitation: 488 nm), and a Coherent Sapphire solid-state laser (RFP excitation: 561 
nm) or the very similar Nikon N-STORM/TIRF microscope equipped with an Andor 
IXON3 Ultra DU897 electron-multiplying CCD camera. Cell were always imaged under 
a 100X oil immersion objective (NA 1.49) without further magnification. The TIRF 
condition was created using a commercial TIRF mirror setup from Nikon and controlled 
electronically through the imaging software (Nikon NIS-Elements v3.22.00). All TIRF 
imaging was performed with electronic focus drift correction. All TIRF images or time-
lapse series were captured in 16-bit without binning at 35-ms exposure. For the FLINC 
dataset, we estimate that the 561 nm (RFP) laser intensity at the sample is 24 W/cm2. The 
multiplier gain and laser power were kept consistent across all FLINC experiments 
involving wild-type Dronpa (DpTT, FLINC-AKAR1, FLINC-EKAR1, FLINC-AKAR1-
TA, FLINC-EKAR1-TA, and FKBP-Dronpa/FRB-TagRFP-T-CAAX) reported in this 
article. However, since mutant and control constructs displayed disparate intensities, 
multiplier-gain and laser power were varied in order to obtain proper exposure. We 
performed laser and multiplier gain calibration, and found both to be linear. Therefore, 
the data presented for mean intensity comparison between wild-type DpTT, mutant DpTT, 
and controls (Figure 3.2b,d,e) were normalized to a gain of 1 and laser power of 100% by 
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applying the appropriate correction factor. Skewness calculations were performed using 
home-built Matlab software, and pcSOFI calculation and normalization were performed 
using the Localizer software.48 Unless otherwise noted, the interval between frames was 
35 ms (~28.6 Hz). 
 
Statistical Methods 
All statistical significance was tested using Welch’s t-test (two-sided, 95% confidence 
interval). All error bars mark the values of the standard error of the mean (s.e.m.). For 
pcSOFI and STORM measurements, single-cell responses were summarized from at least 
two separate experiments, each with multiple cells, over at least two passages. In the case 
of migrating CHO cells, cells in both wild-type and TA groups were excluded if their 
migration direction could not be unambiguously established. 
 
Size-exclusion chromatography (SEC) 
All SEC experiments were performed on a GE ÄKTA protein purification system using a 
Superdex 200 column at a flow rate of 0.2 mL/min. Affinity-purified Dronpa and 
TagRFP-T protein stock solutions were first further purified individually using SEC. The 
pure fractions of each FP were then pooled, mixed at a 1:1 molar ratio, and concentrated 
to a total protein concentration of approximately 120 µM; the stoichiometry was verified 
at 1.00:1 using absorption spectroscopy followed by spectral deconvolution. A total of 
150 µL of the mixed stock solution was subsequently examined with the same SEC 
parameters to resolve any additional oligomeric states present in the concentrated mixture 
(Figure 3.3a). Collected fractions were subjected to absorption spectroscopy and spectral 
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deconvolution in order to determine the concentration of Dronpa and TagRFP-T in each. 
A peak at approximately 92 kDa that was not observed in the chromatographs of the 
individual FPs was found to contain a stoichiometric ratio of approximately 2.5 TagRFP-
T molecules to 1 Dronpa. It is known that TagRFP-T forms dimers at high concentrations. 
Since Dronpa and TagRFP-T are each 30kDa, both size and stoichiometry verified the 
presence of a trimeric FP complex between a TagRFP-T dimer and a Dronpa monomer. 
 
Analytical ultracentrifugation (AUC) 
All sedimentation velocity (SV) experiments were conducted in a Beckman-Coulter 
Optima XL-A analytical ultracentrifuge at 50,000 rpm and 20°C. A set of initial SV 
experiments were performed using purified TagRFP-T, Dronpa, and their mixture at the 
concentrations of 12, 10, and 12/10 µM, respectively, which found that the association 
constant was weaker than 104 M−1. Three further SV experiments were then collected 
using highly concentrated proteins: (1) TagRFP-T alone at 171 µM detected at 595 nm; 
(2) Dronpa alone at 172 µM detected at 435 nm; and (3) a mixture of TagRFP-T (171 
µM) and Dronpa (172 µM) detected at 595 nm. The individual Dronpa and TagRFP-T 
samples were fit to normalized g(s*) distributions using DCDT+ (version 2.4.1) with 
apparent weight average sedimentation coefficients equal to 2.4 S and 3.7 S, respectively. 
The sedimentation coefficient distribution function for the mixed sample was poorly 
described by a sum of non-interacting species, indicating an association between the two 
components. However, the sedimentation coefficient for the Dronpa+TagRFP-T complex 
could not be accurately determined because the population of the species was low. To 
obtain an estimate of the association constant, we further analyzed the data using 
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SedAnal (version 6.01.6926), which allows direct boundary fitting using mass action 
equations. The above sedimentation coefficients were used in an initial fitting attempt to 
a simple A+B ↔ C association model, which converged poorly. We reasoned that the 
sedimentation coefficients may be depressed in the mixed sample due to molecular 
crowding and therefore set them to values 10% lower than their original estimates for 
subsequent fitting using a range of sedimentation coefficients for the complex to obtain 
estimates of the association constant. A typical fit is shown in Figure 3.3b. The calculated 
maximum sedimentation coefficient for a spherical shape of the Dronpa + TagRFP-T 







Any asymmetry in the complex shape would lead to lower sedimentation coefficients. 
Because the complex sedimentation coefficient could not be experimentally determined, 
we fit the data by fixing it at several different values to obtain the subsequent association 
constant. These are shown in Table 3.1, in which the Ka varies between 1090 M−1 and 
6280 M−1 for reasonable values of the complex sedimentation coefficient. Using these 






Table 3.1 Analytic Ultracentrifugation of Dronpa-TagRFP-T fusion 
Summary of SedAnal best fit values of the association constant obtained 
using estimates of the Dronpa+TagRFP-T complex sedimentation 
coefficient. This range of Ka values provides limits for the association 
constant between Dronpa and TagRFP-T. 
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Single Molecule Fluorescence Characterization 
For single-molecule imaging, 30-mm round cover glasses (No. 1, VWR Corporate 
Headquarters, PA) were sequentially cleaned by ultrasonication in 1% Alconox (Alconox 
Inc, NY), water, ethanol and 1M KOH. PEG and Biotin-PEG (Laysan Bio) were coated 
on the clean cover glass according to a published protocol49. A Hybriwell (Secure-Seal, 
Grace) is pasted on the cover glass and sealed by epoxy. The assembled chamber was 
incubated with A) 0.01mg/ml neutravidin B) 1mM Biotin-NTA (Biotium) in PBS for 
10min sequentially. Each step was followed by 1X PBS wash for twice. His-tagged 
purified TagRFP-T or DpTT was diluted in 1X Tris buffer with different salt (300–
3000mM NaCl) concentration to a final protein concentration about 100 pM. 
Immobilization was done by incubating the final TagRFP-T or DpTT solution in the 
chamber for 10 min and wash by the same buffer once. Single molecule fluorescence 
imaging was performed in the buffer without protein on an Olympus IX-71 inverted 
microscope under a 60X, 1.45 NA TIRFM objective. A home-built optical system with 
561 nm solid-state excitation laser (Sapphire, Coherent, Santa Clara, CA) and an 
EMCCD camera (iXon DU897E, Andor Technology, Belfast, Northern Ireland) was used 
to examine the samples (emission: ZET488/561m, Chroma Technology, Rockingham, 
VT). An iris aperture was used to restrict the laser spot size to 150×150 pixels (~700 
µm2). The laser power density was attenuated by a ND filter (NE10A, Thorlabs, NJ) to 12 
W/cm2. Single-molecule image streams were collected with maximum EM Gain (300) in 
16-ms integration time for 2000 frames. Molecules were detected by local maximum 
searching using ImageJ plugin ThunderSTORM50. Aggregated molecules were filtered by 
removing high intensity spots (>3sigma). The spots closer than 1 pixel (267nm) were 
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discarded to guarantee signal is from single molecules. Signal of the spots in every single 
frame was integrated from a 3×3 ROI centered at the ThunderSTORM detections. 
Background was subtracted by the whole frame averaged intensity. The real photon count 
is obtained per instruction from camera manufacturer (Andor). The autocorrelation 
curves were calculated from the intensity trace of individual spots in Matlab (xcorr 
function) and normalize to the autocorrelation value at time lag of zero. All 
autocorrelation curves were averaged to a single autocorrelation function (ACF) for each 
condition. 
TagRFP-T or DpTT solution in the chamber for 10 min and wash by the same 
buffer once. Single molecule fluorescence imaging was performed in the buffer without 
protein on an Olympus IX-71 inverted microscope under a 60X, 1.45 NA TIRFM 
objective. A home-built optical system with 561 nm solid-state excitation laser (Sapphire, 
Coherent, Santa Clara, CA) and an EMCCD camera (iXon DU897E, Andor Technology, 
Belfast, Northern Ireland) was used to examine the samples (emission: ZET488/561m, 
Chroma Technology, Rockingham, VT). An iris aperture was used to restrict the laser 
spot size to 150×150 pixels (~700 µm2). The laser power density was attenuated by a ND 
filter (NE10A, Thorlabs, NJ) to 12 W/cm2. Single-molecule image streams were collected 
with maximum EM Gain (300) in 16-ms integration time for 2000 frames. Molecules 
were detected by local maximum searching using ImageJ plugin ThunderSTORM50. 
Aggregated molecules were filtered by removing high intensity spots (>3sigma). The 
spots closer than 1 pixel (267nm) were discarded to guarantee signal is from single 
molecules. Signal of the spots in every single frame was integrated from a 3×3 ROI 
centered at the ThunderSTORM detections. Background was subtracted by the whole 
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frame averaged intensity. The real photon count is obtained per instruction from camera 
manufacturer (Andor). The autocorrelation curves were calculated from the intensity 
trace of individual spots in Matlab (xcorr function) and normalize to the autocorrelation 
value at time lag of zero. All autocorrelation curves were averaged to a single 
autocorrelation function (ACF) for each condition. 
 
Photophysical Characterizations 
For dark-state conversion (DSC) measurements, HeLa cell expressing nuclear-
localized TagRFP-T/DpTT were illuminated with a 561 nm solid-state diode-pumped 
laser (Genesis MX, Coherent) through a custom-built inverted microscope at an intensity 
of ~ 8–10 kW/cm2. A 629/56 nm band-pass filter (Semrock) was used to remove 
excitation from emission. Epi-fluorescence from the cells was collected using a PMT 
(Hamamatsu Photonics) and subsequently the PMT photo-current was converted to 
voltage using a custom-built trans-impedance operational amplifier for better signal to 
noise ratio. Fluorescence signal was digitized using a data acquisition card (DAQ, 
National Instruments) at a rate of 1 MHz. Pulsed illumination was achieved using an 
acousto-optic modulator (AOM, Gooch & Housego, 35210-BR). Cells expressing FPs 
were bleached continuously for 0.1 s and fluorescence traces were collected for further 
analysis. The raw fluorescence data were background-corrected and spline-fitted for 
smoothing. The fluorescence traces had three distinct features: a rapid decay up to 100 µs 
time-scale, a flat region in 100–1000 µs region, followed by a slow decay in ms time-
scale. Hence, the fluorescence traces were fitted with a 3-exponetial function using equi-
distant time-points in log scale. The fastest time-constants and its corresponding 
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amplitude from the fitting results were considered as DSC time-constants and percent 
DSC respectively51. To measure the ground-state recovery (GSR) time-constants, cells 
expressing nuclear-localized TagRFP-T/DpTT were excited with pulse-trains having 2 
ms exposure time and varying inter-pulse delays (dark time) ranging from 5 µs to 10 ms. 
Fluorescence traces collected using the pulsed excitations were used to compute percent 
recoveries using the following equation without further processing: 
PR=(FR−FB)/(FL−FB)×100, where PR is the percent recovery. FL, FB, FR are the 
fluorescence intensities at initial point, after 2 ms exposure, and after the recovery 
between pulses, respectively. To measure the GSR time-constants, FPs were excited with 
pulse-trains having 2 ms exposure time and varying inter-pulse delays (dark time) 
ranging from 10 µs to 50 ms. A home-built software (Matlab) was used to compute 
percent recoveries of the fluorescence and finally percent recovery vs. dark time plots 
were fitted with single exponential to extract GSR time-constants52. 
Excited state lifetimes of purified TagRFP-T and fluorescent DpTT were 
measured on a Fluro Time 100 commercial TCSPC system (PicoQuant) using 560 nm 
laser excitation with a repetition rate of 2.5 MHz. Lifetime measurements were 
performed using purified proteins in PBS buffer (pH=7.4) at appropriate dilutions. 
Figure3.4D displays the fluorescence decays of the proteins and instrument response 
function (IRF). The fluorescence traces of the FPs were fitted with iterative reconvolution 
with a bi-exponential function and using measured IRF of the system. Intensity-weighted 
average excited state lifetime of TagRFP-T and DpTT were 2.45 ns and 2.40 ns, 





Table 3.2 Summary of photophysical measurements 
Average values for fluorescence lifetime, percentage of dark-state 
conversion possible in the sample (% DSC), time constant of DSC 




Direct Stochastic Optical Reconstruction (dSTORM) Microscopy 
The primary antibodies used in these experiments were mouse anti-AKAP79 (BD 
Biosciences, 610314) and rabbit anti-Phospho-(Ser/Thr) PKA Substrate (“pPKAsub”, 
Cell Signaling, 9621). The AKAP79 antibody was used 1:50 dilution; the anti-Phospho-
(Ser/Thr) PKA substrate antibody was used at 1:200 after a dilution series test was 
conducted. The secondary antibodies used in these experiments were AlexaFluor® 568 
and AlexaFluor® 647 (Life Technologies) at dilutions of 1:2000 and 1:1000, respectively. 
Saponin from Quillaja Bark, sodium borohydride, glutaraldehyde (GA), and normal goat 
serum (NGS) were from Sigma-Aldrich; paraformaldehyde (PFA) from Electron 
Microscopy Sciences; glycine from Fisher Scientific; bovine serum albumin from Roche 
Diagnostics. Cells plated in 35mm dishes were washed three times in HBSS and 
appropriately pre-treated (or no pre-treatment) for 15 min. at 37° C, then washed with 
PBS before fixation using 4% PFA, 0.2% GA PBS for 10 minutes at room temperature. 
All subsequent steps were performed on a shaker; saponin was always used at 0.0005%; 
all solutions were at pH 7.4. Cells were quickly rinsed in PBS after fixation and quenched 
with freshly made 0.1% NaBH4 ice-cold PBS. Following 3X PBS washes of 5 min. each, 
cells were permeabilized and blocked for 1 hour at room temperature in 10% NGS + 
saponin PBS, followed by 3X saponin PBS washes of 5 min. each. Primary antibodies 
were made to working concentrations in 1% BSA + saponin PBS. Cells were incubated 
with primary overnight at 4° C, followed by 3X saponin PBS washes of 5 min. each. 
Secondary antibodies were made working concentrations in 1% BSA + saponin PBS. 
Cells were incubated with secondary antibodies for 1 hour at room temperature in the 
dark. All remaining steps were performed in the dark. Cells were washed 3X saponin 
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PBS for 5 min. each followed by washing 3X PBS for 5 min. each. All samples were 
post-fixed in 4% PFA PBS for 10 min. at room temperature, and quickly rinsed in PBS 
and quenched with 3X 100mM glycine PBS for 5 min. each. The cells were washed 3X 
PBS for 5 min. each and stored in PBS at 4°C in the dark until imaging within 24 hours. 
All STORM imaging was performed on a Nikon Ti microscope under total-internal 
reflection (TIR) condition, using a 100X/1.49 NA Apo TIRF objective. Images were 
collected within a 256 × 256 pixel ROI on an Andor IXON3 Ultra DU897 electron-
multiplying CCD camera using the multicolor continuous mode setting in the Nikon 
Elements software. Power of the 568 nm and 647 nm excitation (as well as activating 405 
nm excitation) was adjusted to enable stochastic blinking behavior within the ROI. The 
images were reconstructed and drift-corrected using the Nikon N-STORM software.  
 
pcSOFI analysis of FLINC data 
Using the Localizer software48, we performed second- and third-order, cross-
cumulant SOFI calculation to process each time series and generate a pcSOFI image. 
Briefly, fluorescence intensity fluctuation data from each local pairs of pixels were 
utilized to calculate the cross-cumulants (or “pcSOFI values”), which quantifies the 
degree or strength of fluctuation. The nature of the pixel pairing allows the algorithm to 
refine the location of each scalar pcSOFI value at a resolution higher than the original 
image pixel density. Simplistically, the use of n-th order cumulant calculation allows n-
fold improvement in resolution. Our calculation accounts for photobleaching. In 
accordance with the analytical derivation for the pcSOFI value (section “Analytical 
expression for normalized pcSOFI analysis” of this document), the pcSOFI images were 
 147 
normalized pixel-wise by the averaged intensity to address biosensor distribution. Each 
pcSOFI image was then deconvolved using Localizer over 5 iterations assuming the 
standard deviation of the PSF is 1.0 pixels. After pcSOFI analysis, the images were 
exported into 32-bit floating point TIFF files and analyzed using ImageJ (v. 1.47g).  
 
Analytical expression for normalized pcSOFI analysis 
The uneven distribution of the biosensor over the cell complicates the evaluation 
of the biosensor response (Figure 3.7a,c). We addressed this by normalizing the pcSOFI 
images pixel-wise, dividing the pcSOFI value by the time-averaged intensity using a 
linearly interpolated averaged intensity image. To derive an expression for the pcSOFI 
signal, we assumed that FLINC is well modeled by fluorophores that continuously and 
reversibly cycle between two different states: a non-fluorescent (dark) state and a 
fluorescent (bright) state with a molecular brightness of ε (expressed in, for instance, 
photons emitted per second). We further assume that the bright state converts to the dark 
state at a rate constant kBD and recovers with rate constant kDB. The resulting 2nd order 
pcSOFI signal for time lag τ is given by: 
𝐺(𝜏) = 𝑁𝜀!
𝑘!"𝑘!"
(𝑘!" +  𝑘!")!
𝑒!(!!"! !!")! 
where N is the number of molecules contributing to the pixel under consideration. This 
reveals that the pcSOFI signal is sensitive to both the fluctuation dynamics and the local 
concentration. Normalizing the pcSOFI value by the time-averaged fluorescence intensity, 




𝑘!" +  𝑘!"
𝑒!(!!"! !!")! 
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Therefore, the normalized pcSOFI value remains sensitive to emission fluctuations but is 
independent of the local concentration. If we further consider the fluctuating fluorescence 
signal to be a mixture of two species (e.g. the same biosensor in high and low FLINC 
states), we can demonstrate that normalization by intensity I gives a similar result even in 
this more general case. We simplify the chromophore rate kinetic terms above using: 
𝑓! =
𝑘!"
𝑘!" +  𝑘!"
𝑒!(!!"! !!")!, 𝑓! =
𝑘!"
𝑘!" +  𝑘!"
𝑒!(!!"! !!")!, 




𝑁!𝜀! 𝑓!! + 𝑁!𝜀! 𝑓!!
, 
where the subscripts 1 and 2 designate the species in mixture. Since in practice, these two 




α𝑁!𝜀!!𝑓!!𝑓!! + (1− α)𝑁!𝜀!!𝑓!!𝑓!!
α𝑁!𝜀! 𝑓!! + (1− α)𝑁!𝜀! 𝑓!!
=
α𝜀!!𝑓!!𝑓!! + (1− α)𝜀!!𝑓!!𝑓!!
α𝜀! 𝑓!! + (1− α)𝜀! 𝑓!!
 
where α is the fraction of high-state FLINC biosensors. Again, the normalized pcSOFI 
value is clearly independent of the total number of molecules Nt. Moreover, normalized 
pcSOFI remains a function of the high FLINC fraction (α). Therefore, under both a 
simplified and general consideration, our analytical scheme can effectively remove 
labeling density dependence, allowing us to measure the biochemical activity of interest. 
Since the average intensity can only be estimated from the diffraction-limited data, 
normalized pcSOFI values are slightly less optimal than theoretical predictions. However, 
our resolution analyses show that the resulting resolution gain compares well with theory. 
We demonstrate the capability of this normalization scheme using plasma membrane 
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targeted Dronpa. Without normalization, Dronpa concentrations were clearly different at 
local regions of the membrane; such disparities were abolished in the normalized pcSOFI 
image; this is supported by the corresponding profile plots showing the effect of 
normalization within a selected region (averaged in the y-axis) (Figure 3.7e, inset). The 
normalized pcSOFI values are used throughout the paper (e.g., Figure 3.7b,d). 
 
Signal-to-noise ratio analysis 
We conducted a series of simulations designed to examine the sensitivity of the 
sensor response to the signal-to-noise ratio (SNR) of the input time-series data. Briefly, 
we simulated a movie consisting of 848 images, each of size 35x35 pixels, containing 
approximately 250 molecules. This simulation includes full modeling of the blinking of 
the individual emitters and also the photon counting noise and electron multiplication 





where 𝜇! and 𝜎! are the average and standard deviation of the signal detected by pixel i 
over the entire time series.  At each condition, we simulated the difference in normalized 
pcSOFI signal between ON/OFF states of the biosensor and repeated with different 
emitter brightness to simulate imaging under various SNR. Each set of conditions was 
repeated nine times to examine the error magnitude. The observed change in normalized 
pcSOFI value was essentially constant starting from an SNR (from the fluorescence 
fluctuation) of 2, beyond which the contribution of noise is very small. Analysis of an 
experimental dataset from a CHO cell found an SNR of 2.8, suggesting that noise in the 
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fluorescence fluctuation time-series has a negligible effect on the response of the FLINC-
based biosensors.  
Separately, we utilized a published method of Delete-1 jackknife resampling53 to 
estimate the signal-to-noise ratio within the pcSOFI image. In this method, the sequence 
of N fluorescent images used to generate a pcSOFI image was used to generate N distinct 
image sets in which a single image in the original set was omitted. The pcSOFI 
calculation was then performed using each of these resampled image stacks to yield N 
distinct estimations for the cumulant at each pixel. The uncertainty of the pcSOFI value 
at each pixel was then estimated in order to calculate the SNR, which serves as an 
estimation of the precision of the pcSOFI value at each pixel. This is shown in Figure 3.5. 
We determined that the SNR of the pcSOFI value is very high, denoting a high accuracy 
in activity measurement.  
 
Resolution analysis 
The resolution achieved in FLINC imaging was estimated using two previously 
reported methods. Firstly, resolution was determined by the measurement of a feature of 
known size, which then allowed an estimate of the resolution using Gaussian fitting. 
FLINC-AKAR1 was targeted to actin filaments in live HeLa cells using the Lifeact 
targeting motif54. Profiles of actin filaments from normalized pcSOFI images were fitted 
with Gaussian models (Matlab 2014a, “fit” function), and the averaged full-width-half-
maximum (FWHM) across multiple filaments is reported as the resolution. The average 
Gaussian FWHM was 179 ± 6 nm (n = 7) for 2nd order images and 116 ± 6 nm (n = 7) for 
3rd order images (Figure3.9a,b). Secondly, the maximum achieved resolution was 
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examined using two converging features in the pcSOFI images. Profile lines were drawn 
through the junction of two clearly visible and converging filopodia. The maximum 
theoretical resolution for a given order of cumulant analysis was reached when only two 
pixels separate the filopodia, and the resolution was reported as twice the pixel size. 
Therefore, 2nd order analysis allowed the resolution of features separated by 160 nm; 3rd 
order analysis resolved features separated by 107 nm (Figure 3.9c-e). 3D surface 
illustrations were plotted using Matlab (2014a).  
 
Puncta analysis for FLINC imaging 
To examine the characteristics of the high activity puncta observed in some of the 
conditions, we segmented the pcSOFI images and collected statistics on the puncta. A 
128x128 region of interest (ROI; 104 µm2) was selected for each cell from deconvolved 
normalized pcSOFI images. These ROIs were chosen to include the basal membrane and 
avoid filopodia extensions. The ROIs were then thresholded using ImageJ (v. 1.47g, 
Intermodes method) and analyzed automatically by the built-in Particle Analysis function. 
The number of puncta and approximate diameter of the particle for a given condition 
were summarized and reported in the text. We further examined the stimulated change in 
the fractional area occupied by the puncta in each ROI across many constructs and 
pretreatment. For this second type of analysis, the total area occupied by the puncta at 
each time point, as identified by the above analysis, was summed and normalized by the 
total ROI area (128x128). The fractional area for each time point was then normalized by 
that of the time point immediately before chemical stimulation, and the tabulated result 
across many cells for each construct/pretreatment/stimulation combination was then 
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reported in Figs. 2G and 3E. Puncta analysis on the filopodia and basal membrane 
regions of migrating CHO cells was performed in a similar fashion on the entire cell by 
categorizing individual punctum into different regions based on cell morphology and 
distance from front-edge. While the migrating cells displayed a large range of pcSOFI 
values, threshold was set to capture only the top 2%, most highly active pixels within 
each cell via image histogram for comparison. Consistent with the observed PKA activity 
gradient, highly-active puncta were seldom found toward the back of the cell. The 
analyzed puncta PKA activities were reported as an average in each category for each cell 
(n = 9), for which Figure 3.14e is representative.  
 
Estimating the diffusion of probes due to STAD-2 pretreatment 
To analyze the possible diffusion of the probe molecules, we made use of a 
version of image correlation spectroscopy55. Multiple datasets containing only the cell 
body were created by cropping the pcSOFI dataset to 100x100 regions of interest 
containing the full time-series in the experiment. The image correlation over this region is 
as follows: 
𝑟 𝜉, 𝜂, 𝜏 =
𝛿𝑖(𝑥,𝑦, 𝑡)𝛿𝑖(𝑥 + 𝜉,𝑦 + 𝜂, 𝑡 + 𝜏)
𝑖 !  
where …  denotes averaging over all x, y, and t. 𝜉, 𝜂, 𝜏 denote the selected spatial lags 
and temporal lag in units of pixels and frames. 𝛿𝑖(𝑥,𝑦, 𝑡) is the fluctuation in the 
fluorescence detected in the pixel at (x,y,t), compared to the average intensity of the 
image at time t, 𝛿𝑖 𝑥,𝑦, 𝑡 = 𝑖 𝑥,𝑦, 𝑡 −  𝑖 !. For our datasets, the possible spatial shifts 
𝜉 and 𝜂 are determined by the pixel size of the camera, and the possible temporal lags 𝜏 
are determined by the camera exposure time. The resulting correlation function is 
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Gaussian-like and decreases in amplitude with increasing 𝜏. It can be shown that the 
variance of the peak as a function of lag time is related to the diffusion coefficient as: 
𝜎! 𝜏 = 2𝜎PSF! + 2𝐷𝜏 
where 𝜎PSF!  is the variance of the point-spread function and D is the diffusion coefficient. 
In our calculation, we determine the variance 𝜎! 𝜏  by fitting the correlation signal for 
each time-lag using a 2D Gaussian function. While deviations arise for longer lag times 
due to the decreased signal in the correlation, the resulting behaviour is approximately 
linear for lag times up to about 12 or more exposures. Using these fits, we found that 
probes in STAD-2-pretreated HeLa cells displayed a diffusion coefficient of 0.075±0.02 
µm2/s (n=3), which is not significantly different from the diffusion coefficient of 
0.097±0.005 µm2/s (n=5) in scramble-control-pretreated cells. The movement of a 
biosensor over the duration of SOFI does not pose a problem as long as the movement 
within a single exposure is not too large. Our exposure time is 35 ms. We estimate that 
the biosensor travels approximately (0.075~0.097µm2/s*35ms)1/2 = 51-58 nm between 
each exposure, smaller than the pixel size we employed (160 nm).  
 
Post-processing and cluster analyses of dSTORM imaging data 
The persistence of fluorescence for longer than the frame rate and the blinking of 
the fluorophore can result in multiple localizations from a single emitter. Therefore, prior 
to analysis, we first corrected for over-counting by grouping the localizations under the 
criterion that localizations within a 100 nm radius and a given dark time (td) period could 
be from the same molecule. We used a published method for determining the appropriate 
dark times for each fluorophore.56,57 The number of distinct molecules identified was 
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determined for different values of the dark time. These data were then fit to the following 
equation, describing two timescales for blinking: 
𝑁 𝑡! =  𝑁(1+ 𝑛!"#$%,!𝑒
(!!!!)
!!"",!  + 𝑛!"#$%,!𝑒
(!!!!)
!!"",!) 
Here, N(td) is the number of molecules identified for a given dark time, N is the real 
number of fluorescent molecules, nblink,1 and nblink,2 are the number of dark state 
conversions occurring with average dark state lifetimes toff,1 and toff,1, respectively. For 
Alexa568, the fit showed that 5.8 blinks per molecule occurred for dark states with a 
lifetime of 1.3 frames (20ms), and 5.4 blinks per molecule occurred for dark states with a 
lifetime of 22.4 frames (336ms) (Figure 3.11a). For Alexa647, the fit showed that 1.6 
blinks per molecule occurred for dark states with a lifetime of 70 frames (1.1s), and 1.7 
blinks per molecule occurred for dark states with a timescale of 3.1 frames (46ms) 
(Figure 3.11b). Values of the dark time were chosen to be double the lifetime of the 
longer blinking timescale, or 140 frames for Alexa647 and 45 frames for Alexa568. 
We employed a variety of complementary clustering/correlation analyses. Mean 
shift clustering58 of the STORM data was performed in MATLAB as was described 
previously59. Briefly, the multivariate kernel density function, f(x), is used to estimate the 
point density of multidimensional data weighted by a spatial kernel, K(x): 








where n is the number of data points, h is the bandwidth of the kernel, d is the dimension 
(here, d=2). For this study we used a Gaussian kernel and truncated the kernel at a 
𝑥 − 𝑥! /ℎ > 2. This kernel density function is used to estimate the density gradient to 
allow iterative progression towards local density maximum. Thus, a random point in the 
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STORM dataset is selected and the estimated density gradient is used to iteratively move 
the estimated mean towards the local density maximum, or centroid, until it converges. 
Then clusters are defined by grouping points together that contribute to this local 
maximum. We disregarded clusters with 10 or fewer localizations. See Figure 3.11c1,c2 
for representative results of the clustering on AKAP79 and pPKAsub localizations, and 
the nearest-neighbor pair display (Figure 3.11c3). The convex hull of each cluster was 
determined using the built-in MATLAB function convhull, and this area was used to 
calculate an approximate diameter. To analyze the association between AKAP79 and 
PKA activity, the nearest pPKAsub cluster centroid to each AKAP79 cluster centroid was 
identified based on Euclidian distance. From the pair centroid distances we could 
generate a histogram for each cell to characterize the spatial association compared to 
random (Figure 3.11c4). For the multiplexed FLINC/STORM data, an analogous 
histogram can be obtained by connecting each AKAP79 cluster to the nearest 
microdomain identified by FLINC (Figure 3.11c5). Separately, we estimated that the 
average experimental error in colocalization between the two color channels was 44.3 nm, 
as measured by the centroid distances between clusters of localizations in different color 
channels from many 100 nm Tetraspeck beads (Life Technologies). 
 To analyze the spatial scales of clustering, the Ripley’s K analysis60 was 
performed for 5µm x 5µm regions for r values ranging from 1 to 1000. The Ripley’s K 
function is given by the following equation: 







,   𝛿!" =  




where A is the area of the region being analyzed, n is the total number of localizations in 
that area, and dij is the distance between molecules i and j. Molecules within a distance of 
r of the edge of the region of interest are not used in the analysis to eliminate edge effects. 
The Ripley’s K function for a random distribution scales with the area of a circle with 
radius r. To create a statistic that scales linearly with R, the L function is defined as:  
𝐿 𝑟 =  
𝐾(𝑟)
𝜋  
To eliminate the dependence on r, L(r)−r is plotted, so that a random distribution will 
have an expected value of zero for all values of r. The peak of the L(r)−r curve represents 
the length scale of maximum clustering. To generate the 95% confidence interval for 
random clustering, Ripley’s K analysis was performed on 200 simulated randomly 
dispersed data sets with the same number of molecules as the dataset to which it is 
compared. These datasets were generated by choosing uniformly distributed random 
numbers for x- and y-coordinates within the region of interest. The values of L(r)−r were 
then ranked for each value of r, and the fifth-percentile and ninety-fifth percentile values 
were plotted.  
 To study the co-clustering of AKAP79 and pPKAsub, a published method based 
on Getis and Franklin’s local pattern analysis61,62 was used. Here a value of L(r) is 








, 𝛿!" =  
1 𝑖𝑓 𝑑!" < 𝑟
𝑒𝑙𝑠𝑒 0
 
To analyze self-clustering of AKAP79 (Figure 3.11d1), Lself,i is calculated by counting 
the number of molecules of AKAP79 (index j) within a radius r of a molecule i of 
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AKAP79 and normalizing it appropriately. Lcross,i, on the other hand, is calculated by 
counting the number of pPKAsub molecules (index j) within a radius of r of molecule i of 
AKAP79 (Figure 3.11d2). This analysis was performed using a value of R of 200nm, 
corresponding the approximate length scale of clustering of AKAP79. Plots of Lcross(200) 
vs. Lself(200) were generated (Figure 3.11d3), and a threshold of L(r)=250 was used to for 
both Lcross and Lself to divide the plot into quadrants. This threshold was chosen because, 
in all regions examined, AKAP79 molecules with a Lself value above 250 were well-
clustered, while those with an Lself value below 250 were not. This analysis allows for the 
calculation of the proportion of AKAP79 molecules that are found in clusters as well as 
the proportion that do or do not co-cluster with pPKAsub.  
 
Personal Contributions 
 I cloned FLINC EKAR as well as performed the subsequent pcSOFI imaging with 
FLINC EKAR to characterize it. I also performed the jackknife resampling of the FLINC 
AKAR data. Furthermore, I wrote the analysis scripts and performed the spatial pattern 
analysis of the single and two-color STORM data, including Ripley K and the bivariate 
version of Getis and Franklin local pattern analysis. I wrote the parts of the manuscript 
corresponding to the jackknife resampling and spatial pattern analysis of STORM data, 
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Methylation of the tails of histone proteins is a key regulator of chromatin 
packing and organization. Tri-methylation of lysine 9 of histone 3 (H3K9me), for 
example, plays a key role in formation and maintenance of constitutive heterochromatin. 
Here we describe the engineering of a high affinity label for H3K9me3 based on the 
chromodomain from chromobox protein homolog 1 (CBX1). We then used the mutant 
CBX1 protein to create live-cell sub-diffraction limit resolution maps of H3K9me3 in the 
nucleus using two different superresolution microscopy methods: photochromic 
stochastic optical fluctuation imaging (pcSOFI) and photoactivated localization 
microscopy (PALM). We demonstrate that the mutant CBX1 chromodomain performs 
considerably better than wild type CBX1 chromodomain for live cell PALM imaging and 
results in images comparable to STORM imaging with anti-H3K9me3 antibodies. 
 
Introduction 
Imaging histone PTMs has generally required immunofluorescence staining in 
fixed cells. However, this approach precludes the study changes of the distribution of 
histone modifications over time. FRET-based approaches have allowed live cell imaging 
of histone modifications. However, they require exogenous expression of histone 
peptides and cannot measure endogenous histone PTMs1-3. Recent approaches to allow 
for live cell imaging of endogenous histone modifications have involved fluorescent 
labeling of antibody fragments, such as scFv-FP fusions4 or fluorophore-labeled antigen 
binding fragments (Fabs)5. These techniques require domains that are large, unstable, and 
prone to aggregation in the intracellular environment. The use of histone PTM binding 
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domains from non-histone proteins is a possible alternative; however their use is limited 
by low binding affinity and specificity. Recent work has demonstrated an FP-fused 
bromodomain for live cell visualization of acetylation of lysine 14 on histone 3 
(H3K14ac), but dimerization of the domain was necessary to have sufficient affinity6. 
Another approach is to directly engineer mutant binding domains that enhance the 
binding affinity with the PTM of interest. Chromodomains, which are found in many 
histone-interacting proteins and mediate binding with methyllysine, are a good candidate 
as a starting point because they are small (<10 kDa), Here we demonstrate the 
engineering of a the chromobox protein homolog 1 (CBX1) domain to enhance the 
affinity approximately 10 fold. We then use this domain to create sub diffraction limit 
resolution maps of tri-metylated histone 3 lysine 9 (H3K9me3) in live cells.  
 
Results and Discussion 
Engineering a chromodomain to bind to H3K9me3 with enhanced affinity 
To identify candidate chromodomain residues critical for the recognition of 
H3K9me3, computational modeling of the interaction energetics of chromodomains 
binding to methyllysine containing peptides was performed. A molecular interaction 
energy component-support vector machine (MIEC-SVM) model7-11 was created for 13 
different  heterochromatin protein 1 (HP1) or Polycomb-like proteins family binding to 
457 different peptide sequences (Figure 4.1), starting with either a structure from the 
Protein Data Bank (PDB) or from homology modeling12,13. This model was then used to 
select important sites on the CBX1 chromodomain to enhance binding to the H3Kme3 
chromodomain. First, a list of sites on CBX1 that were important for recognition of 
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specifically of H3K9me3 compared to non-binding peptides was compiled. Then a list of 
sites important for binding to all CBX1 binders compared to the non-binder H3K27me3 
was compiled to identify residues generally important for binding. Residues that were too 
conserved among chromodomains or did not contribute sufficiently to the binding energy 
difference of binding vs. non binding petides were filtered (Figure 4.2). Sites 59, 60, and 
62 were identified as potential sites important for binding to H3K9me3, and 22, 25, and 
59 were identified as potential sites generally important for binding. 
Residues 22, 25, 59, 60, and 62 on CBX1 were randomized using degenerate 
codons (NNK), and yeast surface display screening was performed using a biotin-labelled 
H3K9me3 peptide. The selected mutants from the yeast surface display screening were 
then tested for their affinity for H3K9me3 by a fluoresescence polarization binding assay. 
The two mutants (V22E/K25S/D59F and V22E/K25E/D59S) demonstrated enhanced 
binding to H3K9me3 compared to the wild type domain (0.32 and 0.21 µM, respectively, 
compared to 2.78 µM for the wild type domain) (Figure 4.3). However, only weak 
binding to the H3K27me3 peptide was observed. The V22E/K25E/D59S variant was 
screened against a MODified Histone Peptide Array (Active Motif), containing 384 
histone marks. The screen demonstrated that CBX1(V22E/K25E/D59S) maintained the 
specificity of  the wild type CBX1 (Figure 4.4).  
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Figure 4.1 Flow chart of MIEC-SVM Model 
a). Flow chart of MIEC-SVM that predicts binding specificity between 
chromodomains and methyllysine peptides. Complex structures between 
13 chromodomains and 457 peptides were constructed by 
computationally mutating peptide sequence from a template complex for 
each chromodomain (Virtual Mutagenesis). From the modeled complex 
structures, MIEC terms between peptide-protein residues at the binding 
interface were computed. The MIECs and the binding/non-binding label 
(obtained from microarray experiments) for each domain-peptide pair 
were input to a LASSO logistic regression model to select most 
predictive MIECs (LASSO feature selection). These selected MIEC 
features were then used to train an SVM model to discriminate binding 
from non-binding events. b). Performance of MIEC-SVM model on 
three different peptide groups (all peptides, singly modified peptides, 
and multiply modified peptides). The MIEC-SVM model showed 
consistent performance regardless of the number of modifications on the 
peptides, indicating that chromodomain-peptide recognition share the 
same MIEC features for singly and multiply modified peptides. c). SVM 
decision value distribution of the four classes of peptides (binders/non-
binders with single or multiple modifications). Binders and non-binders 
are well separated regardless of the modification number. d). Pair-wise 
Jensen-Shannon (JS) divergences between the SVM decision value 
distributions of the four classes. The differences between any binder 
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Figure 4.1 (continued) class and non-binder class (regardless of the 
PTM number) are large (larger JS divergence value): singly modified 
binder-singly modified non-binder, JS = 0.468 (p-value < 1.0 x 10-20); 
singly modified binder-multiply modified nonbinder, JS = 0.396 (p-
value < 1.0 x 10-19); multiply modified binder-single modified  non-
binder, JS = 0.704 (p-value < 1.0 x 10-20); multiply modified binder-
multiply modified non-binder, JS = 0.603 (p-value < 1.0 x 10-20). In 
contrast, binder (or non-binder) peptides are similar to each other 
regardless of the PTM numbers: JS values of 0.113 for binders (p-value 
= 7.0 x   10-15 for statistical similarity) and 0.027 for non-binders (p-
value = 6.1 x 10-10). All p-values were calculated based on the 
background distributions of JS divergence of randomly selected decision 










Figure 4.2 Selection of key residues using MIEC-SVM Model 
Selection of key sites to randomize for the yeast display experiment with 
the CBX1 chromodomain.  Sites “A” and “B” are just two representative 
residues being analyzed for site selection for demonstration purposes.  
The other strategy of selecting residues to randomize on CBX1 





Figure 4.3 Measuring Binding of CBX1(V22E/K25E/D59S) using 
Fluorescence Polarization Binding Assay 
Dissociation constant (KD) values obtained from fluorescence 
polarization binding studies between the WT CBX1 and MPP8 
chromodomains, along with the V22E mutants isolated from yeast 
surface display selections.  The KD values were derived from a 
nonlinear regression equation after performing experiments in triplicate  
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Figure 4.3 (continued) against 1 nM H3K9me3  (NH2-
ARTKQTARK(me3)STGG-mini-PEG-K(5-fam)-NH2) and 1 nM 
H3K27me3 (Ac-QLATKAARK(me3)SAPA-mini-PEG-K(5-fam)-NH2) 
peptides.  KD values towards H3K27me3 are based on visual 
approximation from unsaturated binding curves, for the V22E mutants, 
up to 180 µM of each protein was used in an attempt to get a binding 
curve to H3K27me3. 
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Figure 4.4 Peptide array screening of the V22E/K25E/D59S CBX1 
chromodomain mutant 
An Active Motif histone peptide array, containing 384 peptide spots 
printed in duplicate, was screened against 1 nM of the GST-CBX1 
mutant.  Spots were visualized by chemiluminescence and the spot 
intensities were analyzed by Active Motif array analysis software.  The 
height of the y-axis (specificity factor) represents the ratio of the average 
intensity of all array spots containing the mark (listed on the x-axis) over 
the average intensity of spots not containing the mark. 
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Superresolution Mapping of H3K9me3 with CBX1(V22E/K25E/D59S) 
We aimed to test whether we could use CBX1(V22E/K25E/D59S) to create 
superresolution spatial maps of the H3K9me3 modification in the nucleus of living cells. 
Under two different superresolution imaging modalities, photochromatic stochastic 
optical fluctuation imaging (pcSOFI)14 and photoactivatable localization microscopy 
(PALM)15, we demonstrated that fluorescently protein-tagged chromodomains can be 
used to visualize H3K9me3 in live cells. As a result, we were able to obtain 
subdiffraction information in live cells of the spatial organization of constitutive 
heterochromatin, marked by H3K9me3 histone modifications and labeled with an 
engineered high affinity chromodomain. 
For pcSOFI imaging, the reversibly switchable fluorescent protein Dronpa was 
tagged to the C-terminal of the CBX1 triple mutant chromodomain (V3E/K6E/D40S) and 
transiently expressed the fusion in HeLa cells (Figure 4.5). In this approach, cross-
correlation analysis of stochastic intensity fluctuations is used to extract subdiffraction 
information on the distribution of a blinking fluorophore. The resulting pcSOFI images of 
the CBX1 triple mutant revealed punctate structures with very high pcSOFI signal, 
regions where the signal is excluded, as well as a meshwork of regions showing moderate 






Figure 4.5 pcSOFI Imaging of H3K9me3 using mutant CBX1 domain 
Representative deconvolved pcSOFI superresolution image of CBX1(V3E, 
K6E, D40S)-Dronpa in HeLa cells (left). Diffraction limited image 
(average image of pcSOFI timecourse) (right).   
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In addition to pcSOFI, PALM imaging was used to create even higher resolution 
spatial maps of the H3K9me3 histone modifications (Figure 4.6a). We tagged 
CBX1(V3E/K6E/D40S) as well as wild type CBX1 with a photoactivatable mCherry 
(PAmCherry) fluorescent protein (Subach et al Nature Methods 2009) at the C-terminus 
and transiently expressed these constructs in HeLa or wild type W8 mouse embryonic 
fibroblasts (MEF) cells. The resulting reconstructed images of CBX1(V3E/K6E/D40S) 
reveal a similar pattern observed in the pcSOFI images: punctate structures with very 
dense labeling as well as a meshwork pattern of moderately high localization density 
interspersed with regions with lower labeling (Figure 4.6a). The wild type CBX1, on the 
other hand, showed a different pattern of labeling. The mutant showed a high level of 
nuclear localization (approximately 85% in MEF and 95% in HeLa cells), impressive 
given the lack of a nuclear localization sequence (NLS) tag in the construct (Figure 4.6b).  
This was an obvious improvement over the WT domain,  and is comparable to fixed-cell 
images created using an antibody against H3K9me3 (Abcam ab8898).   
We then compared the live cell PALM images to fixed cell STORM imaging 
using an anti-H3K9me3 monoclonal antibody and an Alexa647-labeled secondary 
antibody (Figure 4.6). This STORM imaging resulting pattern of staining and relative 
contrast between densely labeled and sparsely labeled regions is more similar to the 
CBX1 triple mutant. We hypothesize that the higher affinity of the triple mutant allows it 
localize to regions where H3K9me3 is present but not as enriched, allowing it to show a 






Figure 4.6 Live-cell PALM imaging of H3K9me3 with mutant CBX1 
domain compared to Fixed-cell Immunostaining 
a). Representative reconstructed PALM image of HeLa cells (top row) and 
MEF cells (bottom row) transiently transfected with CBX1 
(V22E/K25E/D59S)-PAmCherry (left) CBX1-WT-PAmCherry (center), 
or fixed-cell, immunostained STORM image with Alexa647-labeled anti-
H3K9me3 antibody (right). All scale bars are 10µm.  b).  Quantification of 
fraction of PALM localizations located within the nuclear region for HeLa 
cells (top) and MEF cells (bottom) (unpaired two-tailed t-test). Mut: 
V22E/K25E/D59S triple mutant, WT: wild type. 
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We subsequently performed live-cell PALM and fixed-cell STORM microscopy 
on a D5 MEF cell line with a double-knockout of Suv39h, the methyltransferase 
responsible for methylation of H3K9me3. It has been shown that, while double knockout 
of Suv39h does reduce the amount of H3K9 methylation, it does not abolish it entirely, 
but rather there is residual methylated H3K916. While no nuclear labeling was observed 
with the wild type CBX1, nuclear labeling was observed with the mutant CBX1 and with 
the anti-H3K9me3 antibody (Figure 4.7). We hypothesize that due to the lower affinity of 
the wild type CBX1, it was not able to effectively label the lower concentration of 
H3K9me3 in the Suv39h knockout line. Consistent with the anti-H3K9me3, the mutant 
CBX1 but not the wild type CBX1 was able to detect the residual H3K9me3 present 
despite the knockout of the methyltransferase. 
Furthermore, we tested the degree of co-localization of the triple mutant with the 
antibody in two-color fixed STORM imaging in HeLa cells (Figure 4.8). The extent of 
co-localization was determined using a published method based on a bivariate version of 
Getis and Franklin’s local point pattern analysis (Figure 4.8b, Figure 4.9)17. We measured 
that an average of 63% of localizations of the CBX1 mutant co-clustered with the 
H3K9me3 antibody, and 94% of H3K9me3 antibody localizations co-clustered with 
mutant CBX1 (V22E/K25E/D59S).  This data is consistent with the peptide array data 







Figure 4.7 Live cell PALM and fixed cell STORM imaging of H3K9me3 in 
Suv39h double knockout MEF cells 
a). Representative reconstructed PALM image of MEF D5 Suvh39h-/- 
cells transiently transfected with CBX1 (V22E/K25E/D59S)-PAmCherry 
(left) CBX1-WT-PAmCherry (center), or fixed-cell, immunostained 
STORM image with Alexa647-labeled anti-H3K9me3 antibody (right). 





Figure 4.8 Two-Color STORM Imaging with CBX1 mutant and anti-
H3K9me3 Antibody 
a). Representative two-color STORM image of HeLa cell labeled withanti-
H3K9me3 ab and Alexa Fluor 647 secondary antibody (magenta) and 
Flag-CBX1mutant/Alexa Fluor 568-anti-Flag ab (green). White represents 
strong co-localization. b). CBX1 (V22E/K25E/D59S) and H3K9me3-
antibody (ab) (Abcam ab8898) co-localization analysis. Extent of co-
clustering of CBX1 (V22E/K25E/D59S) and H3K9me3-ablocalizations in 
two-color STORM images was measured using a bivariate version of 
Getis and Franklin’s local point analysis17. For each localization in one 
channel, the number of localizations in the other channel within 200nm 
was counted. A number above 150 represents co-clustering. Shown here 
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are the proportion of Figure 4.8 (continued) localizations for CBX1 
(V22E/K25E/D59S) that co-clustered with the H3K9me3 antibody (left) 
and the proportion of H3K9me3 antibody localizations that co-clustered 
with CBX1 (V22E/K25E/D59S) (right). Each data point represents the 





Figure 4.9 Bivariate Getis-Franklin Co-clustering Analysis of 
CBX1(V3E/K6E/D40S) and anti-H3K9me3 antibody 
Bivariate Getis-Franklin single molecule co-clustering analysis of 
H3K9me3 and CBX1(V3E/K6E/D40S). An anti-H3K9me3 antibody, 
labeled with Alexa647, and CBX1(V3E/K6E/D40S), labeled with 
Alexa568, were co-imaged in fixed HeLa cells using STORM microscopy. 
a). Representative scatter plot showing molecular localizations for the 
anti-H3K9me3 antibody, color-coded with the values for L(200) (left) and 
Lcross(200) (center), which reflect the number of localizations in its own 
species or of the other species, respectively, within a 200 nm radius of 
each localization. A scatter plot of Lcross(200) and L(200) is shown 
(right). Localizations with a Lcross(200) score above 150 were considered 
co-clustered. b). Representative scatter plots showing molecular 
localizations of CBX1(V3E/K6E/D40S) in the same region, color-coded 
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with L(200) (left) or Lcross(200) (center). A scatter plot of Lcross(200) vs. 




Materials and Methods 
Template Construction and Conformational sampling 
 The template chromo-peptide complex structures for 13 chromodomains (CBX1-8, 
MPP8, CDYL1, CDYL2, SUV91, SUV92) were obtained from either PDB or homology 
modeling based on a previously described method12,13. The peptide in each chromo-
peptide structure contains 9 residues (truncated if more than 9) with tri-methylated lysine 
on the 8th position. For each chromo-peptide template, molecular dynamics (MD) 
simulation was performed for conformational optimization and sampling. Binding 
interface residue backbone RMSD was evaluated for the 13 chromodomains to verify the 
equilibrium. After the production run, 8 snapshots were evenly selected from the 
trajectory between 3 to 5 ns as chromo-peptide binding complex templates for each 
system. The chromo-peptide binding complex templates were mutated in silico to each of 
the 457 peptides. Restrained by the computational cost, we performed 5000 steps of 
energy minimization instead of MD simulation to optimize all the complex structures 
obtained through mutation.  (See supporting information for details.) 
  
Calculation of molecular interaction energy components 
 Residue pair-wise energy decomposition on minimized structures was performed 
by mm_pbsa.pl in the assisted model building with energy refinement (AMBER) 
package18-20, and a molecular interaction energy component (MIEC) profile was 
generated based on the energy decomposition result consisting of chromo-peptide MIEC 
profile and peptide internal MIEC profile. For chromo-peptide MIEC profile, the energy 
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contributions from 8 snapshots are averaged and all residue pairs less than 10 Å were 
included to reflect binding characteristics of the chromo-peptide interactions. The 
sequences of chromodomains were aligned using sequence and structural information to 
match residues from different domains. For peptide internal MIEC profile, MIECs of the 
adjacent peptide residue pairs were calculated to represent the conformational preference 
of the peptide. MIEC profile for each chromo-peptide interaction contains 158 chromo-
peptide residue pairs and 8 peptide-peptide pairs (664 energy components in total).  
 
Construction, Training and Testing of the MIEC-support vector machine model  
LASSO (Least Absolute Shrinkage and Selected Operator) logistic regression 
method21 was applied to the MIEC profile to select informative features to construct the 
MIEC-support vector machine (MIEC-SVM) model (see Table S4). All SVM training 
and tests were conducted using the LIBSVM package22. The polynomial kernel function 
was used. A nested cross validation was performed to exclude an over-fitting issue in the 
training process (see supplementary material for details and Table S5).  Both 3-fold cross 
validation and leave-one-domain-out (LODO) test were performed to evaluate the 
prediction accuracy of the MIEC-SVM model.  
 
Selection of Candidate Sites to Randomize on the CBX1 Chromodomain 
 To select for sites to randomize in the CBX1 library in order to enhance its 
binding affinity towards H3K9me3, we used two different strategies.  The first was to 
identify residues important for binding H3K9me3 compared to non-binding peptides.  
Comparison of MIEC components of H3K9me3 binding to non-binder components, 
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along with avoiding choosing residues that were too conserved amongst chromodomains, 
we constructed a ranked list of candidate sites that showed the largest energetic 
difference between binders to non-binders.  The second strategy was essentially the same 
as the first strategy except that we selected sites generally important for CBX1 binding by 
comparing all CBX1 binder MIECs to a representative non-binder (H3K27me3).  Again, 
a conservation filter was applied to prevent selection of structurally important residues on 
the chromodomain.  
 
Yeast Surface Display Library Construction and Screening  
The five sites selected for randomization on the CBX1 chromodomain (residues 
22, 25, 59, 60, and 62 of NCBI P83916.1) were fully randomized using primers 





3’ (N is any base, K is g/t, M is c/a).  The library was ligated into a modified pYD1 
vector, followed by transformation into EBY100 yeasts using the LiAc/ssDNA/PEG-
3350 method23, resulting in approximately 106 transformants.  The yeast surface display 
library was screened using biotin-Y-ahx-RTKQTARK(me3)S-NH2 (ahx = 
aminohexanoic acid) as the antigen24.  Yeast were sorted on a BD FACSAria II (Moores 
Cancer Center, University of California San Diego).  Random hits were sequenced by 




Fluorescence Polarization  
 Fluorescein-labeled methylated histone peptides (Karebay) were used for KD 
determination by serial dilution in triplicate.  The peptides used were H3K9me3 (NH2-
ARTKQTARK(me3)STGG-minipeg-K(5-fam)-NH2) or H3K27me3 (Ac-
QLATKAARK(me3)SAPA-minipeg-K(5-fam)-NH2) at a concentration of 1 nM.  The 
serial dilutions were in TBS buffer (25 mM Tris, 125 mM NaCl, pH 8).  FP values were 
read on a  DTX 880 Multimode Detector Beckman Coulter plate reader with excitation 
filter at 485 nm and two emission filters at 535 nm equipped with polarizers.  Data were 
fit to a nonlinear regression equation using GraphPad Prism 4 software.    
 
 
Molecular Cloning, Cell Culture, Transfection, and Immunocytochemistry 
 The CBX1 chromodomain (either wild type or the triple mutant) was cloned into 
a pcDNA3 vector and fused to the N-terminus of the photoactivatable mCherry protein.  
HeLa and MEF cells were cultured using standard protocols and plated on 3.5 cm glass-
bottom dishes for imaging.  For live-cell photoactivated localization microscopy (PALM) 
imaging, HeLa and MEF cells were transiently transfected using either Lipofectamine 
2000 (Thermo-Fisher Scientific) or Polyjet (SignaGen).  For fixed-cell stochastic optical 
reconstruction microscopy (STORM) imaging, cells were fixed with 4% 
paraformaldehyde (PFA) for 20 min, and then washed with 100 mM glycine in Hank’s 
balanced salt solution (HBSS) to quench the free PFA. Cells were permeabilized and 
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blocked in a permeabilization solution with 0.1% Triton-X, 0.2% BSA, 5% goat serum, 
and 0.01% sodium azide in HBSS. The cells were then incubated overnight at 4°C with 
an anti-H3K9me3 antibody (Abcam ab8898) at a 1:500 dilution, followed by 1-2 hours 
with goat anti-rabbit Alexa 647-conjugated antibodies at 1:1000 dilution. The cells were 
then post-fixed again in 4% PFA, quenched with 100 mM glycine in HBSS, and washed 
with HBSS to prepare for imaging. Immediately before imaging, the media was changed 
to STORM-compatible buffer (50mM Tris-HCl pH 8.0, 10mM NaCl, 10% glucose) with 
560 µg/ml glucose oxidase, 170 µg/ml catalase, and 7.7 mg/ml mercaptoethylamide. 
For the two-color STORM imaging, the cells were incubated over night at 4°C 
with a mouse anti-FLAG antibody (Sigma F1804, for detection of FLAG-tagged CBX1) 
at a 1:200 dilution and with a rabbit anti-H3K9me3 antibody (Abcam 8898) at a 1:500 
dilution. They were then incubated 1-2 hours with goat anti-rabbit and anti-mouse 
antibodies, labeled with Alexa647 and Alexa568 respectively, at a 1:1000 dilution.  
 
Super-Resolution Imaging and Image Analysis 
 STORM and PALM images were obtained using a Nikon Ti TIRF microscope 
with N-STORM, an Andor IXON3 Ultra DU897 EMCCD, and a 100X oil-immersion 
TIRF objective. Photoactivation was driven by a Coherent 405 nm laser, while excitation 
was driven either with a Coherent 561 nm laser or a 647 nm laser. Illumination was done 
in a “near-TIRF” format, in which the TIRF angle was adjusted so that molecules in the 
nucleus were illuminated. All image analysis and image reconstruction was performed 
using the Localizer software25 in the Igor Pro 6.3 environment. STORM and PALM 
images were segmented using the GLRT algorithm25 and localizations were fit using 
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Gaussian fitting. Reconstructed bitmap images were created in which intensity 
corresponds to the number of localizations in each box in a 0.2 pixel-wide grid.  For two-
color STORM imaging co-localization analysis, the protocol can be found in 
supplemental methods. 
 
Two-Color Stochastic Optical Reconstruction Microscopy (STORM) Imaging Co-
Localization Analysis 
 
 For two-color STORM imaging, acquisitions for the two channels were 
interleaved. Image analysis and reconstruction were performed using the N-STORM 
software package.  Before the co-clustering analysis was performed, over-counting of 
localizations due to persistence of the fluorescence of an emitter for multiple frames and 
blinking was corrected by grouping localizations within 100nm separated by less than a 
particular dark time (td) and treating them as coming from a single emitter. The 
appropriate dark time for each fluorophore was determined using a published method26,27. 
The nmber of localizations after such grouping was determined for varying values of td , 
and the data were fit to the following equation. 
𝑁 𝑡! =  𝑁(1+ 𝑛!"#$%,!𝑒
(!!!!)
!!"",!  + 𝑛!"#$%,!𝑒
(!!!!)
!!"",!) 
Here, N(td) is the number of localizations after grouping with a particular dark 
time, N is the real number of fluorescent molecules, nblink,1 and nblink,2 are the number of 
dark state conversions occurring with average dark state lifetimes toff,1 and toff,2, 
respectively. For Alexa568, the fit showed that 0.8 blinks per molecule occurred for dark 
states with a lifetime of 11.4 frames, and 1.4 blinks per molecule occurred for dark states 
with a lifetime of 90 frames. For Alexa647, the fit showed that 0.3 blinks per molecule 
occurred for dark states with a lifetime of 9.2 frames, and 0.7 blinks per molecule 
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occurred for dark states with a timescale of 171 frames. Values of the dark time were 
chosen to be approximately double the lifetime of the longer blinking timescale, or 180 
frames for Alexa568 and 340 frames for Alexa647. 
Co-clustering analysis was performed using a published method17,28, based on a 
bivariate version of Getis and Franklin’s local point pattern analysis using MATLAB 
software. For each localization in one channel, the number of localizations in the other 
channel within 200nm was counted, with that statistic being called L(200)cross. A 
threshold of L(200)cross of 150 was set for a particular localization to be considered co-
localized with a cluster of the other channel. We then determined the percentages of 




 I performed the cloning of the fluorescent protein-fused CBX1 wild type and 
mutant variants, as well as the pcSOFI, PALM, and STORM imaging of all these 
constructs in HeLa and MEF cell lines. I also performed the subsequent data analysis for 
the various superresolution imaging experiments, including pcSOFI analysis, single-
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Chapter 5 Concluding Remarks  
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We have presented here three novel and distinct technologies that push the 
boundaries of genetically encodable fluorescent biosensors. These new molecular tools 
allow the researcher to collect types of information otherwise unavailable or difficult to 
attain. The genetic encodability of these molecular tools make them well suited for 
studying the spatial and temporal distribution of PTMs. Genetic encodability allows the 
sensors to be engineered on the DNA level and then synthesized by the cell’s own 
machinery. This ability allows the researcher to take advantage of the breadth of protein 
domains found in nature as well as those who have been mutated and engineered for a 
particular behavior. It further allows for the precise targeting of the tools to particular 
sub-cellular locations. Furthermore, genetic encodability allows for the system to be self-
contained. Once the cell of interest contains the DNA construct, no further components 
are required to be added for the tools to function, and the cell can pass it on to its 
daughter cells. Furthermore, the cell continually produces the sensor and replenishes it.  
 For the FLARE biosensors, we demonstrate that the molecular switches 
commonly used in kinase activity and second messenger biosensors, when sandwiched by 
two similar FPs excited with a polarized light source, can cause a measurable change in 
the anisotropy of the light emitted by the FPs. These switches can thus be used to design 
biosensors that are both single-color, allowing for sensor multiplexing, and ratiometric, 
allowing for probe concentration effects to be canceled out. Furthermore, this design is 
compatible with several different color FPs and many different switches, creating a large 
panel of biosensors from which to choose. We demonstrate that FLARE can be used for 
imaging up to three activities simultaneously in the same cell, for monitoring signaling 
activities while they are perturbed by optogenetic tools, and for multiplexed signaling 
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activity monitoring in vivo in live cells. Future work will involve increasing the signal-to-
noise ratio of these sensors, expanding the panel of activities that the biosensors can 
monitor, and using these biosensors for biological applications, such as studying cross-
talk among signaling pathways. Optimization of signal-to-noise ratio is especially 
important for the lower performing cyan and red variants. This optimization may be 
accomplished by changing the FPs used these homo-FRET sensors, or by optimizing the 
switches themselves. Furthermore, adding different linker sequences or optimizing the 
molecular switches themselves may also contribute to optimizing the signal-to-noise ratio. 
Expansion of the tool-kit will also include adapting the FLARE design to study other key 
signaling activities, as well as by targeting these tools to different subcellular locations.  
 The FLINC approach to kinase activity biosensing allows the researcher to study 
localized signaling activities, approaching the level of a signaling microdomain or 
signalosome, in a dynamic way. By connecting a molecular switch to a change in the 
fluctuation behavior of an FP, we can uncover sub-diffraction level information about the 
signaling activity of interest. We demonstrated that they provide a time course of super-
resolved activity maps of kinase activity. In this way, we were able to demonstrate that 
PKA activity is not evenly spread near the plasma membrane, but is considerably 
heterogeneous and highly localized. More precise characterization of the spatial 
architecture of PKA signaling at the membrane, as mediated by AKAP proteins as well 
uncovering the functional implications of this organization are areas of further study. To 
continue to develop the technology, the FLINC biosensor design should be adapted for 
other signaling activities. Furthermore, the approach may be generalizable to other FPs 
for which their fluctuation behavior can be modulated by another protein domain. This 
 200 
motivates the further detailed study of the fluctuation behaviors of FPs and how 
interactions with other protein interfaces may alter them. Likewise, further work will aim 
to apply the FLINC approach with imaging of localized signaling activities in other 
cellular locations than the plasma membrane. Therefore, adapting the technology for 
lattice light sheet imaging would allow for super-resolved maps of signaling activities in 
cellular locations not accessible with TIRF microscopy. 
 Finally, the engineering of a high-affinity chromodomain to serve as a probe for 
H3K9me3 allows for the study of the spatial organization of histone modifications and 
how that relates to chromatin organization and gene expression. We have demonstrated a 
marked improvement in live-cell imaging of H3K9me3 with the mutant compared to the 
wild type CBX1 chromodomain. One of the key advantages of a live-cell probe for 
H3K9me3 is the ability to monitor changes the spatial distribution of heterochromatin; 
therefore, future work will entail performing time course experiments to provide dynamic 
high resolution maps of  H3K9me3, for example during the cell cycle or cellular 
differentiation. Additionally, a similar approach using other histone PTM binding 
domains, such as other chromodomains, Tudor domains, or PHD domains, can be used to 
develop genetically encodable probes for studying other histone modifications.  
  Together these technologies should help provide insights into the fine tuning of 
key cellular functions, such as signal processing and gene expression regulation, in space 
and in time. By uncovering the patterning of dynamics of critical biochemical markers, 
we reveal a new level of complexity in cellular functioning. A particular protein in a cell 
does not have just one function, but many, which may vary from precise subcellular 
location to location, and from one point in time to another.   
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